Privately-Held Companies with Emerging Medical Technologies



EMT (EMERGING MEDICAL TECHNOLOGIES)® DATABASE


1081 Companies to Date | + Regular Updates | Coverage thru 2011



 


The Emerging Medical Technologies (EMT) Database is an online tool for strategic marketing, market research, business development and investment executives seeking discreet and detailed business, market, and competitive intelligence on privately-held companies developing disruptive technologies.

This database currently includes 1081 companies and includes regular updates.

LSI leverages multiple, exclusive data streams to feed this robust database, including:

  • An exclusive license to record the presentations and executive summaries for presenting companies at the prestigious annual Medtech Insight/Elsevier In3 West, In3 East, In3 Medical Device Summit, and In3 Europe meetings (approximately 130 companies per year)
  • CEO presentations and executive summaries from LSI’s quarterly EMT Spotlight meetings (approximately 130 companies per year)
  • Ongoing in-house research efforts (approximately 140 companies per year)

This database is the premier tool for identifying, tracking, partnering with, investing in, or reacting to, emerging companies in the space.


Company Overviews:


Data includes:
  • Key Executive
  • Financing Status and Needs
  • Revenue
  • Development Status
  • Strategic Partnering Needs
  • Contact Info
  • Year Established
  • Website
  • + More
  Executive Summaries:

Data includes:
  • Company Overview (structure, size, year founded, etc)
  • Technology Details
  • Target Markets
  • Competitive Landscape and Differentiation
  • Financial Summary and Sales Forecasts
  • Financing & Partnering Needs
  • IP Position & Status
  • Management Team Overview
  • + More
  CEO Presentations:


Data includes:
  • 10-15 minute slides and corresponding audio
  • Investor/Partner/Business related content -- not product demos or infomercial style videos readily available in the public domain
  • Coverage of all past and future IN3 Conferences

* Depth of coverage varies for each company.
** Coverage includes regular updates on new, emerging companies.

Comprehensive Search Features Include:

Keyword & Exact Phrase Searching:

  Search By Medical Market:


Search By Conference:


 
Search By Company Name:

Search By Region:
   
EMERGING MEDICAL TECHNOLOGIES DATABASE

In addition to the companies covered on the In3 conference circuit, we reveal new companies to you via our active in-house research efforts and quarterly EMT Spotlight meetings.

Technology descriptions for companies currently covered as of 03/09/10 include:

  • Company 1 - Ultrasound catheters for targeted thermal ablation of tumors
  • Company 2 - Implantable devices for the endovascular treatment of hemorrhagic stroke
  • Company 3 - Intravascular temperature management systems and catheters for cardiac and neuro intensive care patients
  • Company 4 - Artificial lung delivers O2 and removes CO2 through a catheter inserted into the vena cava
  • Company 5 - Next-generation non-vascular interventional pulmonary and gastrointestinal stenting technology
  • Company 6 - Devices delivering infrared light to reduce pain and accelerate tissue healing
  • Company 7 - D-ribose, a five-carbon carbohydrate that increases cellular energy, improving cardiovascular health and tissue function
  • Company 8 - Cell-based therapy products for the treatment of heart failure secondary to myocardial infarction
  • Company 9 - Electronic device that closes the gap between drugs and surgery in osteoarthritis of the knee
  • Company 10 - Arthroscopic surgical devices
  • Company 11 - MIST Therapy using non-contact ultrasound to stimulate healthy cells allowing chronic wounds to heal
  • Company 12 - P-15: a small peptide attachment factor for bone formation in orthopedics
  • Company 13 - Minimally invasive needle biosensor for in vivo glucose or lactate monitoring of intensive care patients
  • Company 14 - Non-invasive modality for the treatment of insulin resistance/diabetic neuropathy
  • Company 15 - Methods for eyebrow lifting, non-thermal loading of degradable matrices, and degradable implants
  • Company 16 - Immunodiagnostics of placental recombinant markers to screen the risk of preeclampsia, preterm delivery, and IUGR
  • Company 17 - Next-generation biomaterials using bioactive-ceramics technology platform
  • Company 18 - Aortic arch stent graft
  • Company 19 - Monitor for autonomic nervous system displaying sympathovagal balance in real-time for diabetes/ anesthesia/cardiology applications
  • Company 20 - Portable automated critical care neuro instruments using advanced digital signal processing technology
  • Company 21 - Interventional catheter system for the mechanical recanalization of arterial chronic total occlusions quickly and reliably
  • Company 22 - THERMOCEPS - a handheld, wireless device that stops bleeding during surgical procedures using focused, thermal coagulation
  • Company 23 - Molecular diagnostics based on patented, standardized, next-generation, multi-gene expression (StaRT-PCR) products and high margin services
  • Company 24 - Automated, continual blood glucose monitoring for critically ill patients
  • Company 25 - Real-time, CT-guided, robotically controlled needle drivers for minimally invasive cancer therapy
  • Company 26 - Noninvasive, site-specific drug delivery technology to deliver compounds to the posterior segments of the eye
  • Company 27 - Prevention of scarring caused by disease, medical intervention, or trauma via a beta emitting biopolymer
  • Company 28 - A wireless, early detection and auto-alerting heart monitor system for outpatient and homecare markets
  • Company 29 - Trabectome, an FDA-cleared, minimally invasive medical device technology for the treatment of open angel glaucoma
  • Company 30 - Helical stent providing enhanced abilities and flexibilities in drug delivery, scaffolding, and embolic protection
  • Company 31 - Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant
  • Company 32 - Bioresorbable polymer implants for use in a variety of orthopedics and spine surgical applications
  • Company 33 - CardioPath System that prevents embolic events by removing plaque and thrombus found in diseased arteries
  • Company 34 - BioSilicon, nano-structured porous silicon for applications in drug delivery, diagnostics, tissue engineering, and orthopedics
  • Company 35 - Conservative Motion Preservation technology including minimally invasive facet joint replacement
  • Company 36 - Catheters designed to diagnose, terminate, and treat cardiac arrhythmia during EP and ablation procedures
  • Company 37 - Artificial total intervertebral disc capable of normal physiological movement and weight loading
  • Company 38 - A wireless personal emergency alert system that integrates with, and enhances, existing implanted medical devices
  • Company 39 - A smart, communicating cigarette case, online support, and daily e-mails delivering an effective stop-smoking method
  • Company 40 - Minimally invasive disc replacement for chronic back pain
  • Company 41 - Surgical instruments employing thermal welding technology to seal and cut tissue
  • Company 42 - Endoscopy systems allowing physicians to see very small, early-stage cancer and subtle pre-cancerous lesions
  • Company 43 - Rapid, point-of-care in vitro diagnostics
  • Company 44 - AccessAED - portable, compact easy-to-use automated external defibrillators with full energy delivery and complete resuscitation solutions
  • Company 45 - Phase II drug/device combo product for bone regeneration in orthopedic and perio/oral surgery
  • Company 46 - Non-incisional female sterilization
  • Company 47 - Non-irritating dry electrodes now enabling long-term cardiac monitoring
  • Company 48 - Noninvasive ultrasound-based tissue analysis services for early detection of malignant tumors
  • Company 49 - Site-specific biological and drug delivery
  • Company 50 - Posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion
  • Company 51 - AepEX auditory evoked potential depth of anesthesia monitor and aepEX-Fusion servo-controlled anesthesia delivery system
  • Company 52 - Magnesium-based compound that will attach bone to bone and ligaments and tendons to bone
  • Company 53 - Cath lab solution providing rapid onset of circulatory support in patients with acute heart failure
  • Company 54 - Direct, real-time vision through flowing blood to guide therapy inside the heart and vessels
  • Company 55 - Micro-porous ceramic wound treatment device that creates optimal conditions for normal wound healing
  • Company 56 - Endovenous ablation system for varicose veins with 1320 nm CoolTouch laser
  • Company 57 - Impedance Cardiovelocimetry non-invasively measures/ monitors mechanical heart function and disease utilizing a disposable brachial cuff
  • Company 58 - ERBLAN MIS Surgical Devices allow safe entry into virtually any actual or potential anatomical space
  • Company 59 - Continuous, non-invasive glucose monitor for tight glycemic control at the hospital and at home
  • Company 60 - Augmented reality simulators that train surgeons in the skills required for minimally invasive surgery
  • Company 61 - Non-blood contacting, active implantable direct cardiac compression device for the treatment of CHF
  • Company 62 - Continuous blood gas monitoring and cardiac output measurement for the intensive care unit
  • Company 63 - Point-of-care platform technology (CRP & Cyst C) for assessing risk of cardiovascular disease and renal dysfunction
  • Company 64 - Nanotechnology-based cancer therapy with contactless activation of tumor-specific nano-particles, adaptable to all solid tumors
  • Company 65 - Precise miniature robotic technology for spine, knee, orthopedic, and neurosurgery minimally invasive procedures - SmartAssist
  • Company 66 - Virtual Bone Biopsy MRI scanner add-on, allowing noninvasive imaging of bone microstructure for osteoporosis monitoring
  • Company 67 - Implantable blood pump with magnetic levitation technology for patients suffering from heart failure
  • Company 68 - MRI-compatible, precision- guided laser therapy for the treatment of brain tumors
  • Company 69 - Nanomagnetic particles enabling controlled drug delivery and elution for drug targeting and medical device applications
  • Company 70 - Technology for imaging peripheral nerves in regional anesthesiology, pain management, and other markets
  • Company 71 - Catheter-based sealing of heart defects associated with stroke, migraine headaches, and other brain attacks
  • Company 72 - NovoSci Ready System
  • Company 73 - Implantable encapsulated-cell technology for delivery of biological therapeutics to the nervous system
  • Company 74 - Disposable balloon cervical dilator for improved uterine access that decreases pain, avoids tearing and perforations
  • Company 75 - First noninvasive, transcutaneous sensor array that continuously monitors peripheral circulation and/or core body temperature
  • Company 76 - Magneto-Optical Enantiomeric Detection (MOPED) for real-time, non-contact analysis of chiral pharmaceuticals
  • Company 77 - Minimally invasive cancer therapy using Magnetically Energized (ME) Thermotherapy
  • Company 78 - Real-time disposable stereotactic navigation devices for biopsy/targeted therapy compatible with CT, fluoroscopy, and MRI
  • Company 79 - Three-dimensional surgical visualization technologies and expanding portfolio for digital surgical environment and digital healthcare network
  • Company 80 - Second-generation, viscoelastic artificial disc restoring native function to the spine
  • Company 81 - BioDisc, a nucleus replacement product based on an injectable, flexible, and durable protein hydrogel technology
  • Company 82 - Dascor Arthroplasty System, spinal implants technology
  • Company 83 - Osteogenica - bone marrow concentration system
  • Company 84 - Fluidjet devices for open and MIS fusion, discectomy, artificial nucleus, and artificial disc procedures
  • Company 85 - Minimally invasive fusion system
  • Company 86 - Next-generation fusion, motion sparing, and minimally invasive spinal implant products
  • Company 87 - Bioactive synthetic bone graft substitute that is osteostimulative, osteoconductive, antimicrobial, and hemostatic
  • Company 88 - Orthopeutics, LP introduces Intrabrace a new non-surgical, injectable treatment for resisting spinal curvature in scoliosis.
  • Company 89 - 1-Synthetic alternatives to autograft/cadaver-based bone material, 2-Surgical hemostat as an adherent matrix/impermeable barrier to blood flow, 3-Bone augmentation material for injections in osteoporotic spines to treat vertebral compression fractures
  • Company 90 - Compliant artificial lumbar disc with graduated modulus for restoration of normal spine biomechanics/enhanced durability
  • Company 91 - Nucleus replacement device
  • Company 92 - Lumbar spine motion preservation via dynamic stabilization utilizing a semi-rigid rod and screw system
  • Company 93 - Lumbar, thoracic, and cervical fusion devices including less invasive instrumentation; lumbar and cervical artificial discs
  • Company 94 - Advance and commercialize less invasive spinal deformity surgical treatment without fusion
  • Company 95 - Clinical expertise, facility development, new technology, and business services including marketing and contracting
  • Company 96 - Interspinous process implant to treat Lumbar Spinal Stenosis (LSS)
  • Company 97 - Telemeterized natural motion elastomer disc
  • Company 98 - Least invasive approach for the delivery of lumbar fusion and motion preservation therapies
  • Company 99 - Minimally invasive dynamic stabilization device
  • Company 100 - High Intensity Focused Ultrasound for minimally invasive thermal treatment of disc herniation without disc penetration
  • Company 101 - Interactive intraoperative CT scanning technology for image-guided interventions
  • Company 102 - Microplate-based electronic biosensor system for label-free, real-time cell based assays
  • Company 103 - Noninvasive monitor to measure exhaled nitric oxide for the management of asthma
  • Company 104 - A device for the left atrial appendage for stroke prevention in patients with atrial fibrillation
  • Company 105 - Device for the treatment of Barrett's esophagus and prevention of esophageal cancer
  • Company 106 - Blood test for breast cancer measuring 5 protein biomarkers using super-sensitive ELISA with 95% accuracy
  • Company 107 - Totally implantable LVAD that does not interface with circulating blood
  • Company 108 - Percutaneous access management system to provide early ambulation/eliminate major complications, leaving nothing behind in patient
  • Company 109 - Molecular FingerPrinting process for early-stage diagnosis of cancer, enabling point-of-care therapeutics based on gene regulation
  • Company 110 - Percutaneous noninvasive heart valve replacement
  • Company 111 - Microsyringe delivery of cells, genes, and drugs to the vasculature/deep tissues of the body
  • Company 112 - Electronic pill for oral delivery of low bioavailability drugs
  • Company 113 - Bioabsorbable drug eluting stents and stent coatings for treatment of vulnerable plaque and coronary stenosis
  • Company 114 - Implantable Left Ventricular Assist Device (LVAD) for heart failure, needed by 250,000 Americans yearly
  • Company 115 - Blood test that screens/diagnoses cervical cancer without need of a cervical exam/pap smear
  • Company 116 - Capture and analysis of heart sounds leading to rapid and accurate diagnosis of cardiac pathologies
  • Company 117 - Non-contact intelligent medical vigilance for the hospital
  • Company 118 - Controlled fluid delivery system for every medical application without batteries or power cords
  • Company 119 - Genetic and personal history based testing to predict age-specific risk of breast cancer diagnosis
  • Company 120 - IYIA has developed a proprietary, clinically effective device, O2Misly, for treating slow healing foot wounds, primarily diabetic foot ulcers
  • Company 121 - Enteric Dialysis with Kibow Biotics - a food-grade microbial Gel cap formulation towards kidney failure applications
  • Company 122 - Noninvasive Ultra-WideBand medical radar imaging for cardiopulmonary ambulatory monitoring and diagnosis
  • Company 123 - Light-based therapy for eradication of ulcer-causing Helicobacter pylori
  • Company 124 - Device for the treatment of mitral regurgitation and heart failure without requiring open heart surgery
  • Company 125 - Interventional catheter-based system precisely measures stent and arterial size and cardiovascular repair tissue patch products
  • Company 126 - Colon cancer screening and preventing Fecal Occult Blood Test & the O'Regan Hemorrhoid Banding System
  • Company 127 - Long-term, miniature drug delivery implant with physician- controllable, zero-order release characteristics
  • Company 128 - Minimally invasive surgical access system used in laparoscopic surgery
  • Company 129 - Automated implantable pump systems for moving fluids around inside the body
  • Company 130 - Nitric oxide releasing surface treatments for enhanced biocompatibility in medical devices
  • Company 131 - Devices for mechanically induced bone growth, together with a "smart device" system for risk management
  • Company 132 - Technologies that utilize flexible cross linking and sterilization processes which stabilize and sterilize biological tissue for use in orthopedic, wound, oral/dental, spine and neurological, breast, abdominal and thoracic applications
  • Company 133 - Unique microsphere-based technology for chronic/acute wounds
  • Company 134 - Affordable handheld metabolic monitor (indirect calorimeter) with both medical and consumer weight management applications
  • Company 135 - Noninvasive therapeutic ultrasound to enhance perfusion for treatment of acute myocardial infarction
  • Company 136 - In vivo plasmapheresis and ultrafiltration to remove excess fluid from CHF patients in clinical trials
  • Company 137 - Electrode sensor array, with integrated lead wires, simple, accurate and repeatable ECGs
  • Company 138 - Disposables for drawing blood -- percutaneous or from a catheter -- neonates to geriatrics
  • Company 139 - Biomimetic coronary stent coating that prevents restenosis/reduces the need for extended courses of dual antiplatelet therapy
  • Company 140 - Peptide-based therapeutic to enhance stent/graft patency
  • Company 141 - Minimally invasive device-based technologies targeting the treatment of hemodynamic instability and perfusion
  • Company 142 - 1-Bio-therapeutic designed from autologous stem cells and committed to a cardiac lineage before implantation, 2-Corresponding catheter for accurate transmyocardial injection
  • Company 143 - Noninvasive device using muscular counter pulsation (MCP) technology for the treatment of chronic heart failure (CHF)
  • Company 144 - Technology to reshape the heart
  • Company 145 - Catheter-based therapy which increases cerebral perfusion for the treatment of ischemic stroke and vasospasm
  • Company 146 - Stentless aortic valve prosthesis to be delivered via catheter
  • Company 147 - A noninvasive test for endothelial dysfunction using digital (fingertip) thermal monitoring
  • Company 148 - Perfusion monitoring for preventing septic shock, the greatest hospital mortality
  • Company 149 - PeriVasc
  • Company 150 - Minimally invasive interventional radiology/vascular surgery devices
  • Company 151 - AUDICOR uses advanced ECG-heart sound analysis to enable superior diagnosis/monitoring of CHF/ACS patients
  • Company 152 - Pressure and flow sensing systems for vascular and other applications
  • Company 153 - Percutaneous mitral valve repair simulating precision of surgical annuloplasty
  • Company 154 - Surgical and percutaneous cardiac valve repair
  • Company 155 - Minimally-invasive cardiac implantable devices for treating mitral valve regurgitation without atriotomy or cardiopulmonary bypass
  • Company 156 - A wearable continuous ultrafiltration device that removes fluid overload in patients with Congestive Heart Failure
  • Company 157 - Alginate-based embolic material designed to fill blood vessel defects thereby displacing blood pressure effects and preventing vessel rupture
  • Company 158 - A portable laseroptical system for noninvasive differentiation between ischemic stroke and spontaneous intracerebral hemorrhages
  • Company 159 - OmniWave
  • Company 160 - A platelet reactivity test to measure the effect of anti-platelet drugs, particularly aspirin and Plavix
  • Company 161 - An approach using RF energy for shrinkage of the valve annulus to reduce/eliminate regurgitation
  • Company 162 - Catheter-based photoreactive treatment system for endovascular intervention in coronary and peripheral atherosclerotic disease
  • Company 163 - Minimally invasive telemetric and continuous measurement of left atrial blood pressure at heart failure
  • Company 164 - Noninvasive medical device providing low-risk hypoxic treatment that induces appetite suppression and weight loss
  • Company 165 - Multi-Sensing Wireless Catheter platform attached along the GI-Uro tract detecting GERD, incontinence, and other abnormalities
  • Company 166 - SutureLock - a versatile suture-securing knot-replacement device for endoscopic wound approximation
  • Company 167 - Microscope slide scanners and information management software that enable the digitization of pathology
  • Company 168 - Patient recovery system for cosmetic and reconstructive surgery
  • Company 169 - System analyzes a patient's susceptibility to cardiac arrest and consequent need for implantable defibrillator
  • Company 170 - Interventional MRI technology for cardiovascular imaging including detection/treatment of vulnerable plaque
  • Company 171 - Point-of-care IVD platform that provides rapid, accurate, automated laboratory testing using low cost, disposable biochips
  • Company 172 - ATRILAZE
  • Company 173 - Dedicated angioplasty and stent systems for the treatment of arterial bifurcations
  • Company 174 - Specialty and standard electrophysiology catheters that have superior performance, advantageous features, and are affordable
  • Company 175 - Nanotechnologies for use in orthopedic implants, dental implants, and stents
  • Company 176 - Noninvasive neural vision enhancement
  • Company 177 - Disposable, noninvasive, pump-less, and valve-less automatic blood pressure monitor "on-a-chip"
  • Company 178 - Saliva-based consumer diagnostic systems, which enable the development of personalized therapeutics
  • Company 179 - RFID hardware and software platform for test tubes/ apheresis device for blood component separation
  • Company 180 - 3-D tomographic ultrasound imaging system to aid in diagnosing breast cancer
  • Company 181 - Infusion catheter for treatment of tumors which are unresponsive to systemic chemotherapy by the local delivery of drugs and other agents
  • Company 182 - Customized miniature disposable stereoscopic cameras that provide 3D vision, measurements, and image fusion in real-time
  • Company 183 - Medical devices that enable diabetes disease management and the prevention of lower extremity amputations
  • Company 184 - Expert systems and miniaturized hardware for stroke prevention and management and for pre-operative brain protection
  • Company 185 - Dynamic optimization of pacing intervals according to hemodynamic sensors for CRT devices
  • Company 186 - SmartStep
  • Company 187 - Cellular implants for orthopedic, trauma, and spinal applications based on a biological form stable matrix
  • Company 188 - Endoscopically-placed devices to prevent GERD, obesity, and irritable bowel syndrome (IBS)
  • Company 189 - 1- Interventional single-use cardiac support device and drug delivery platform, 2- Implants for use in/with magnetic resonance imaging (MRI) systems
  • Company 190 - Bioabsorbable, bioactive, and drug-releasing medical device products for various fields of surgery
  • Company 191 - Coronary guidewire, to provide real-time ultrasonic measurement of coronary arteries to determine stent size and apposition without exchange of catheters
  • Company 192 - Miniature implantable, continuous blood glucose sensor for diabetics, incorporating noninvasive wireless monitoring
  • Company 193 - Tissue fixation implants, injectable bone grafting biomaterials, and tissue scaffolds with drug releasing properties
  • Company 194 - Non-invasive screening of Peripheral Arterial Disease (PAD), combining postural/infrared blood volume testing
  • Company 195 - Medical devices utilizing radiofrequency and microwave energy which are cost-effective and clinically relevant
  • Company 196 - Unique add on and removable needle safety product that fits to standard glass/plastic syringes
  • Company 197 - Non-invasive airway clearance in ICU patients to prevent ventilator associated pneumonia
  • Company 198 - Technology for the manipulation of adult stem cells to repopulate chronically diseased liver tissue
  • Company 199 - Products that digitize manual breast examination tissue elastic properties into objective computerized visual maps/reports
  • Company 200 - Endotracheal tube with video, self-locking orthopedic implants, structured TPN lipids, cell therapy for cancer, etc.
  • Company 201 - Immediate, active, device-less, and painless topical drug delivery, of small/macromolecules, for local/systemic indications
  • Company 202 - Transdermal delivery system of levodopa (L-DOPA) for the treatment of Parkinson's Disease
  • Company 203 - Magnetically actuated telescopic intramedullary (IM) nail activated by an induced low power directional magnetic field
  • Company 204 - A suite of tools for automated CT Angiography (CTA) diagnostics for Coronary Artery Disease
  • Company 205 - Noninvasive, outpatient bariatric device for overweight/obesity
  • Company 206 - Microsensors and receptors for the real-time measurement of therapeutic drugs and clinical chemistry parameters
  • Company 207 - Bifurcated coronary stent
  • Company 208 - SurfLink
  • Company 209 - Next-generation bio-medical adhesive, used as a filler for aneurysms in various areas of the body
  • Company 210 - Vascular stents and grafts with increased patency by improved flow dynamics, reducing stenosis and restenosis
  • Company 211 - Non-invasive continuous measurement of tissue oxygenation for various intraoperative and post-operative applications
  • Company 212 - A platform aerosol drug delivery nebulizer device for multiple- and single-use applications with disposables
  • Company 213 - Gene-based products for the diagnosis and treatment of spinal disorders
  • Company 214 - The Axya Shoulder Fixation System generates ultrasonic energy for knotless suture welding in shoulder surgery
  • Company 215 - Minimally invasive percutaneous neuromodulation pain therapy
  • Company 216 - Ultraviolet light technologies for the inactivation of RNA viruses in/out of the body
  • Company 217 - Noninvasive mechanical compression for treatment/prophylaxis of lower extremity circulatory disorders such as: PAD/DVT
  • Company 218 - Rapid testing systems led by the Growth Direct
  • Company 219 - Laparoscopic surgeons maintain direct control of the laparoscope movement/placement with GMP's Laparocision
  • Company 220 - Fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify lipid rich plaques in the coronary arteries
  • Company 221 - Small/portable/handheld device for diagnosing brain hematomas
  • Company 222 - Real-time, noninvasive monitoring of blood loss, anemia, and other vital blood measurements
  • Company 223 - A remotely controlled, wireless-powered implantable 230-channel nerve stimulator built on a 15
  • Company 224 - Aesthetic treatment device using collimated high-energy light and laser, delivered simultaneously by fiber delivery system
  • Company 225 - Multi-channel implantable microelectrodes for deep brain stimulation and recording, enabling enhanced neuromodulation therapies
  • Company 226 - Ultrasonic medical devices for minimally invasive therapeutic procedures for treatment of cancer/other healthcare purposes
  • Company 227 - Drug/device products for post-operative pain and orthopedic drug delivery indications using syntinate synthetic absorbables
  • Company 228 - Biomaterial that regulates resorbability and enhances bone regeneration
  • Company 229 - Image-guided therapy for metastatic liver disease
  • Company 230 - Post-proteomics multiplexed MS-based diagnostics/theranostics linked to drug development and personalized medicine
  • Company 231 - A "preventative" vaccine for HIV-AIDs
  • Company 232 - Respiratory diagnostics for noninvasive assessment of airway acidification in Asthma, COPD, and GERD
  • Company 233 - Theramers
  • Company 234 - Laparoscopic surgical access technology based on a No-Seal platform
  • Company 235 - Medical devices, utilizing robust tyrosine-based resorbable polymer systems/pharmaceuticals in surgical barriers/cardiac rhythm management
  • Company 236 - Phase-shifting technology for Contrast Ultrasound imaging
  • Company 237 - Miniature/patient-controllable/valved catheter to improve quality of life/decrease urinary tract infections in patients suffering urinary retention
  • Company 238 - CGRP for the treatment of heart failure
  • Company 239 - Noninvasive device providing substitute vestibular sensory information through the tongue for treatment of balance disorders
  • Company 240 - PuraMatrix injectable synthetic nanofibrous hydrogels for bone, cartilage and soft tissue regeneration, and drug delivery
  • Company 241 - Implanted oscillating field stimulation device which regenerates acute and sub-acute damaged spinal cord nerve tissue
  • Company 242 - Synthetic bone that duplicates the microstructure, composition, and performance of human bone
  • Company 243 - Drug product for the treatment of acute spinal cord injury, cancer, macular degeneration, and glaucoma
  • Company 244 - Nitric oxide-based therapies to accelerate healing of tendon, bone, and other musculoskeletal tissue
  • Company 245 - Biomaterials-based product that augments or replaces the diseased nucleus pulposus of the spinal disc
  • Company 246 - A CE-marked resorbable plating system for cervical fusions allowing for load sharing
  • Company 247 - Low-profile implants/less invasive surgical instruments to treat spinal disorders utilizing fusion and non-fusion technologies
  • Company 248 - A biological and mechanical solution to annular repair and spine fusion
  • Company 249 - Fusion technology platforms and second-generation artificial discs for the lumbar and cervical spine
  • Company 250 - Noninvasive, ambulatory, portable, 3-D traction technology providing an effective and unique therapy for spinal disorders
  • Company 251 - Real-time image-guidance technology with an FDA-accepted accuracy claim of +/-1mm at 1 meter
  • Company 252 - Lumbar dynamic stabilization with MIS compatibility and pedicle screws
  • Company 253 - Rapid table-mounted retraction/surgical site access for MIS placement of hip/knee/shoulder/spine implants
  • Company 254 - Emperor Mobile Spinal Disc, P.E.E.K Cages, Pedicle Screw System, and Saturn Hip Resurfacing
  • Company 255 - Stable and extractable self locking intramedullary nails and proximal femoral fixation
  • Company 256 - 1-LIFEBACK® Spine Programs for non-operative and post-operative spine patients and 2-the LTX 3000® Rehabilitation System
  • Company 257 - Shielded reciprocating tissue sculpturing instrument, able to navigate into neural foramen to relieve nerve compression
  • Company 258 - Catheter-based technology for orthopedic trauma indications providing site-specific tissue drainage and drug delivery
  • Company 259 - Facet fixation system that is a less-invasive/faster alternative to pedicle screw fixation
  • Company 260 - Naturally-derived/non-crosslinked/collagen-based extracellular matrix to repair/remodel damaged tissues
  • Company 261 - Smart devices to harness human physiology for health care, industrial safety, and law enforcement applications
  • Company 262 - Analyze, search, store, mine, share and unlock the power of digital tissue images
  • Company 263 - A protein therapeutic biotreatment that regresses solid tumors and protects against relapses
  • Company 264 - Functional brain imaging centers that identify Alzheimer's, brain injury, stroke, ADHD, bipolar, depression, anxiety, OCD
  • Company 265 - Orbital atherectomy for the treatment of peripheral vascular disease
  • Company 266 - MIS platform technologies for creating cavities in tissue and partially molding an orthopedic implant in situ
  • Company 267 - Porcine-derived tissue devices for ligament, cartilage, bone, and soft tissue replacement and augmentation
  • Company 268 - Physiologic Heart Surgery Pump: reducing post-surgery kidney failure, mortality, and complications cost by 50%
  • Company 269 - Next-generation estrogen-based drug-eluting coronary stent and an orthopedics/sports injury pain management device
  • Company 270 - Repositionable/removable percutaneous heart valve, precision controlled delivery device, and calcified valve encapsulation system
  • Company 271 - Free-floating optical probe with multiple LD scanning and magnetic stabilization for noninvasive blood glucose monitoring
  • Company 272 - Flash Ultrasound
  • Company 273 - IBraces - 100% customized, invisible orthodontic braces designed for efficient, effective treatment of teens and adults
  • Company 274 - PowerCosmetics micro-electronic patches, delivering skincare results faster and more effectively
  • Company 275 - Surgical stapling devices for open and laparoscopic procedures developed for the growing China market
  • Company 276 - Noninvasive device used in the differential diagnosis of disc or facet mediated low back pain
  • Company 277 - Biocompatible polymer implant to prevent or reverse the progression of chronic heart failure and mitral valve regurgitation
  • Company 278 - 1-Low-cost, disposable point-of-care (POC) Pap smear replacement requiring no lab or medical professional; 2-Drug-eluting contraceptive cervical barrier
  • Company 279 - Accommodating and multifocal phakic IOLs, CE-approved for $ billion refractive IOL market
  • Company 280 - An implantable ophthalmic device to treat vision correction associated with Age-Related Macular Degeneration (AMD)
  • Company 281 - Noninvasive medical device for the treatment and prevention of obesity using controlled hypoxia
  • Company 282 - Next-generation biomaterials technology
  • Company 283 - Percutaneously delivered implantable system to treat mitral valve regurgitation and improve congestive heart failure
  • Company 284 - A bioactive ceramic that delivers better/faster spine fusion and bone repair
  • Company 285 - A drug delivery platform that approaches the endovascular bifurcation challenge from a completely different angle
  • Company 286 - The Nano-Pulse measures arterial elasticity and autonomic nervous system function
  • Company 287 - NICOM
  • Company 288 - Advanced optical systems/services that are changing the way doctors evaluate and treat the eye
  • Company 289 - Advanced skin biopsy and wound healing solutions to dermatology, cosmetic, primary care, and oncology clinicians
  • Company 290 - Tissue repair devices exploiting shear force transfer and large-interface substrates for adherent new tissue formation
  • Company 291 - Technology that prepares the spinal disc for a nucleus replacement/minimally invasive fusion device
  • Company 292 - An internal adhesive biotechnology designed for strength, biocompatibility, and ease-of-use with applications in cardiovascular surgery
  • Company 293 - 1-Instant-on/instant-off proximal occlusion funnel catheter, 2-Scoring balloon with drug delivery capability
  • Company 294 - Protein free induction of endochondral ossification, no human origin, not contagious, no soft tissue ossification
  • Company 295 - 1-Cartilage implant for the knee, 2-Injectable cell therapy for the spinal disc/nucleus, 3-Bone graft extender to treat spinal deformities
  • Company 296 - Percutaneous light activation reduces intra-abdominal fat, returning Type 2 diabetic patients towards normoglycemia
  • Company 297 - Diagnostic platform with a test for measuring unbound Bilirubin for the management of newborn jaundice
  • Company 298 - Digital Pulse Analyzer - provides early detection of arterial wall stiffness and biological age of arteries
  • Company 299 - Endothelial management - less trauma combined with new agents for improved healing in vascular interventions
  • Company 300 - Robot-assisted stroke therapy devices
  • Company 301 - The Sensation
  • Company 302 - Resorbable pegylated hydrogel for surgical wound sealing/adhesion prevention/sustained and targeted drug delivery
  • Company 303 - ECG software for assessing acute ischemia and cardiac safety surrogates in clinical trials
  • Company 304 - Spinal implants utilizing elastomeric polymers for non-fusion treatment of disc degeneration
  • Company 305 - Blood tests for: breast cancer/Alzheimer's disease/women's cancers
  • Company 306 - Gradient-based tracking and navigation for MRI - enables MRI-guided intervention, endoscopy and catheterization on any scanner
  • Company 307 - Programmable lab-on-a-chip platform for applications ranging from drug discovery to consumer diagnostics
  • Company 308 - Lectin-based cell adhesion technology which enables stents that traffic cells in the bloodstream
  • Company 309 - Tools for enabling adult stem cell based regenerative medicine
  • Company 310 - ViaDerm - home use transdermal drug delivery system creating microscopic passageways in the top skin layer
  • Company 311 - Ambulatory infusion pumps and disposables that require no programming and use pre-filled solution containers
  • Company 312 - High Intensity Focused Ultrasound for incisionless male surgical sterilization
  • Company 313 - Highly reimbursable orthopedic rehabilitation durable medical equipment
  • Company 314 - Noninvasive blood glucose monitor that will measure glucose in sweat in a disposable dermal patch
  • Company 315 - 1-Soft tissue attachment nanotechnology, 2-Bioactive/biocompatible/osteoconductive synthetic bone filler, 3-Biodegradable fiberglass fiber & composites
  • Company 316 - Disease management system for early detection of heart failure using a noninvasive cardiovascular-sleep prognostic marker
  • Company 317 - Wireless 2000 leads the un-tethered patient vital signs monitoring revolution, using wireless Ultra Wideband (UWB) and Zigbee technologies
  • Company 318 - Biocellulose technology that eliminates the risks/complications/limitations inherent in animal, human, and synthetic biomaterials
  • Company 319 - Spinal implants, cervical, thoracolumbar, interbody, bone substitutes, motion preservation
  • Company 320 - Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniation.
  • Company 321 - Building on an exclusive intellectual property platform for both fusion and non-fusion products
  • Company 322 - Disc Motion Technologies has developed the first posterior lumbar arthroplasty system consisting of an artificial lumbar disc and a posterior dynamic stabilizer.
  • Company 323 - Motion preservative artificial disc
  • Company 324 - Revisable cervical and lumbar total disc replacement that can be converted to fusion
  • Company 325 - Water-resistant adhesives derived from mussels, used as tissue adhesives/anti-bacterial coatings
  • Company 326 - 1-Lumbar cage with integrated fixation screws, 2-Pedicle screw product line, 3-Access systems and implants for use in minimally invasive surgery (MIS)
  • Company 327 - Reintroducing CHYMOPAPAIN, the only proven minimally-invasive therapy for herniated discs; it allows nuclear regeneration.
  • Company 328 - Lumbar system for dynamic stabilization without fusion, artificial discs, and minimally invasive surgery systems
  • Company 329 - Orthopedic products, specifically for upper and lower extremity small bone applications
  • Company 330 - Developing and marketing EEG systems, tools and services for Neurologists, Neurosurgeons, and Neuroscience Researchers
  • Company 331 - Indigo Orb, Inc is a technology leader in "Automatic Detection of Epidural Cavity"
  • Company 332 - Human Globin, a biopolymer to replace animal collagens in dermal fillers and create biomaterials for tissue repair
  • Company 333 - An automated blood glucose monitor for the intensive care unit using near infra-red spectroscopy
  • Company 334 - Minimally invasive surgical technology that uses ionizing radiation to treat wet age-related macular degeneration (AMD)
  • Company 335 - Minimally invasive ophthalmic device therapy for Dry Macular Degeneration and other blindness causing diseases
  • Company 336 - Providing private and hospital-based OB/GYNs, Perinatologists, and Radiologists with integrated reporting and image management systems
  • Company 337 - Single-use rigid endoscopes, with superior image quality, at a reduced per-use cost
  • Company 338 - Portable and networked medical devices such as handheld ultrasounds
  • Company 339 - Non-surgical serum based cure, proven effective for PAD, Diabetic and Cardiovascular disorders
  • Company 340 - Producer of surgical devices including a self-attaching hernia patch, anti-clog surgical drain, and cavity implosion device
  • Company 341 - DART is utilizing an interstitial radiation source that by nuclear decay recoil mechanism emits high-energy alpha particles widely dispersed by diffusion and by convection in the tumor mass
  • Company 342 - BMDSys' Magnetic Field Imaging (MFI) is an absolutely non-invasive, radiation- and side-effect free electro physiological high speed cardiac diagnostic system to identify upcoming heart attacks and sudden cardiac deaths
  • Company 343 - Developing a fully implantable extra-aortic counterpulsation device designed to provide long-term, cost-effective treatment and significantly improve quality of life for heart failure patients
  • Company 344 - Intelligent nasal drug delivery devices for topical, systemic and nose-to-brain applications
  • Company 345 - Handheld device which measures the amount of calories a person requires to maintain body weight
  • Company 346 - Minimally invasive retractors for pelvic surgery to optimize pneumoperitoneum pressure and patient position (OP5)
  • Company 347 - Open-architecture, cryogenic-free MRI systems for orthopaedic, general purpose and interventional applications
  • Company 348 - Growth factor and biomaterial addressing the needs of spinal fusion, osteochondral defects, osteoarthritis, dental medicine, and other indications
  • Company 349 - Non-invasive continuous glucose monitoring device, for patients with diabetes, based on a multi-sensor platform
  • Company 350 - Percutaneous mitral valve replacement system for treatment of mitral regurgitation
  • Company 351 - Total hip replacement system that addresses resistance to wear and resistance to dislocation with ceramic and double mobility
  • Company 352 - Next-generation disposable colonoscope incorporating diagnostic/therapeutic capabilities allowing for a potentially sedation-less treatment
  • Company 353 - Computer-integrated robotic instrumentation/navigation tools for orthopedic surgery
  • Company 354 - Dual function, automatic, handheld sinus irrigator and aspirator for OTC consumer use
  • Company 355 - Less invasive orthopaedic implant solutions employing advanced pliable structured materials and innovative designs
  • Company 356 - Patient controlled analgesia device for pain management
  • Company 357 - Target-specific recombinant human protein focused on spinal fusion surgery
  • Company 358 - Ceramic components for spine, orthopaedic, and other implant needs
  • Company 359 - Non-invasive robotic radiosurgery system for cardiac ablation
  • Company 360 - Integrated wireless monitoring
  • Company 361 - Device based therapy targeting ischemic brain stroke and chronic heart failure
  • Company 362 - Site-specific catheter-guided system to deliver drugs and biologics directly to the adventitia
  • Company 363 - Portable, easy-to-use consumer device that allows for easy, safe and green disposal of used insulin syringes, lancets and pen needles by vaporizing the sharp
  • Company 364 - Portable and easy-to-use tests for the healthcare, veterinary, and consumer markets
  • Company 365 - High-intensity focused ultrasound in a catheter to treat atrial fibrillation
  • Company 366 - Technology using opto-acoustics for functional imaging/cancer diagnosis
  • Company 367 - Infusing normothermic fluids from 10mL/hour-1200mL/minute with 30-second setup through a disposable cassette
  • Company 368 - Methods for treating human tissue based on volumetric bipolar radio frequency ablation (RFA), and surface ablation of tissue
  • Company 369 - Cell-based epicardial patch designed to promote blood vessel growth in ischemic cardiac tissue
  • Company 370 - Human bionic devices that can instantaneously interact with the human body to replace or restore biomechanical or physiological functions
  • Company 371 - Advanced wheelchair technologies
  • Company 372 - Catheter-based devices which rapidly provide quantitative data to the physician about vessel and stent size, suitable for peripheral and cardiac applications
  • Company 373 - Diagnostic methods using microarray gene expression profiling to determine specific properties of tumors
  • Company 374 - Laser, light-based, and radiofrequency devices for aesthetic and medical applications
  • Company 375 - Optical backscatter technology to improve the way cancer is detected and diagnosed
  • Company 376 - Advanced gene expression and DNA quantification products and services
  • Company 377 - Mobile phone-based data collection for chronic disease management
  • Company 378 - StomaphyX™, a sterile, single-use device for use in endoluminal trans-oral tissue approximation and ligation in the GI tract
  • Company 379 - A software based thermal mapping system that will be used in conjunction with CT and planar x-ray imaging systems
  • Company 380 - EXPANSE Vertebral Body Replacement Device for use in the thoracolumbar spine
  • Company 381 - Low-cost, fast, and accurate molecular diagnostic products
  • Company 382 - Devices for the in-office polypectomy/myomectomy market
  • Company 383 - Next generation of laser therapy
  • Company 384 - New pulmonary drug delivery system
  • Company 385 - Molecular diagnostic products for laboratories that are intended to enhance medical care by providing early diagnostic information rapidly
  • Company 386 - Products for the minimally invasive repair of long bone fractures
  • Company 387 - Electromedical/electrotherapeutic equipment
  • Company 388 - Female sterilization technology
  • Company 389 - Precision surgical systems for computer-assisted 3D planning, surgical navigation, and surgeon-controlled robotic surgery
  • Company 390 - Devices for treating cardiovascular disease
  • Company 391 - Telemedicine paired with state-of-the-art ophthalmologic imaging
  • Company 392 - Low cost, easy-to-use, credit-card-sized devices which will allow on-the-spot quantitative diagnosis
  • Company 393 - Noninvasive breast cancer risk assessment device
  • Company 394 - Non-invasive, painless, Navigated Brain Stimulation (NBS) for brain diagnostics and therapy
  • Company 395 - Non-invasive ultrasound body contouring
  • Company 396 - A device that seals blood vessels after hemodialysis as an alternative to central venous catheters for kidney-dialysis patients
  • Company 397 - Fusion and non-fusion spinal implants
  • Company 398 - First viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure ("CHF")
  • Company 399 - Modular hip stem technology and total knee replacement systems
  • Company 400 - Advanced endotracheal tube for intubation, fitted with advanced fiberoptic visualization technology
  • Company 401 - Interventional bronchoscopy devices for lung diseases
  • Company 402 - A portable oxygen delivery and ventilation system
  • Company 403 - Metabolomic profiling of biomarkers for the diagnosis of early forms of dementia and neurodegenerative diseases
  • Company 404 - Neowater®, a water-based nanotechnology which has physical properties that mimic intracellular water
  • Company 405 - AOKit™-bio: an adaptive optics kit for biologists which enhances microscopic imaging
  • Company 406 - Minimally invasive medical devices for patients who are at risk for or have suffered a stroke
  • Company 407 - Products to diagnose the risk for heart attacks by means of assessing endothelial function
  • Company 408 - Ophthalmic formulation of mitomycin-C in a single-use kit, for use in the surgical treatment of glaucoma
  • Company 409 - Arm training device to restore arm movement in stroke patients who have experienced arm paralysis
  • Company 410 - Wireless seizure alarm systems for people with epilepsy
  • Company 411 - RNA-based therapeutics
  • Company 412 - Automatic tools to support image visualization, lesion detection and quantification, temporal evolution assessment, and automatic reporting in chest and abdominal CT scans
  • Company 413 - A portable breath collection apparatus (BCA) which can collect breath samples virtually anywhere, for highly sensitive laboratory analysis
  • Company 414 - Transvaginal, ultrasound image-guided HIFU device, capable of real-time guidance and monitoring of therapy
  • Company 415 - Minimally invasive catheter-based ablation technologies to treat atrial fibrillation and other cardiac arrhythmias
  • Company 416 - Devices that use bio-electric stimulation therapy (bio-current) to treat hard-to-heal wounds
  • Company 417 - Miniature blood pump, designed to be placed superficially like a pacemaker, for the long-term treatment of chronic heart failure (CHF)
  • Company 418 - Biodegradable surgical adhesive for seroma reduction in plastic surgery
  • Company 419 - SutureCross™: Knotless Anatomic Fixation System for double row arthroscopic rotator cuff repair
  • Company 420 - New generation of high-power/compact lasers for cosmetic, dermatology, pain management, and wound applications
  • Company 421 - Contrast agents/molecular imaging for detection using a modified porous Silicon (mpSi™) platform
  • Company 422 - Delivery of proteins and peptide drugs without burst, with near-zero order release, and with high bioavailability
  • Company 423 - Monitoring system to replace the manual assessment of labor progress with real-time/continuous information
  • Company 424 - 1-Bone cement to replace PMMA-based materials, 2-A liquid hydrogel wound dressing able to cure rapidly and in situ
  • Company 425 - Easy-to-use, instrument-free, disposable molecular diagnostic tests
  • Company 426 - Third-generation biodegradable annuloplasty rings
  • Company 427 - Low-mass PFO closure system capable of repairing the defect from within the tunnel
  • Company 428 - BQT®, a non-invasive point-of-care diagnostic test for osteoporosis and bone fracture risk
  • Company 429 - Optical cell sorters used in stem cell/cell therapy treatments for cancer, autoimmune disease, and regenerative medicine applications
  • Company 430 - Non-fusion spinal solutions that control segmental motion/maintain the neutral zone simultaneously
  • Company 431 - Wireless electronic skin patch sensors for the real-time measurement/monitoring/diagnosis/clinical management of cardiac arrhythmias
  • Company 432 - Optical coherence tomography for evaluation of human tissue microstructure with real-time depth visualization
  • Company 433 - Non-molecular bacterial screening, identification, and antibiotic susceptibility testing
  • Company 434 - The CADscreen system performs a non-invasive, 30-second test to identify the risk of heart disease
  • Company 435 - Products for the early detection of lung and oral cancers
  • Company 436 - A "plug & play" system for treating non-invasive, curative, and palliative cancers and precursors
  • Company 437 - Fully modular total hip replacement systems to reduce wear/add longevity
  • Company 438 - Spinal cage with dynamic stabilization/MIS placement (3mm access) and easily revisable
  • Company 439 - Hand-held device to monitor post-operative/trauma patients for early warning signs of sepsis or infection in the bloodstream
  • Company 440 - Patient-centric data system and analysis tools for translational medicine and research
  • Company 441 - A minimally invasive electromagnetic navigation system for early detection of lung cancer
  • Company 442 - Advanced suturing technology for minimally invasive/NOTES/bariatric/cardiac/other surgical specialties
  • Company 443 - Bioprosthetic heart valve with a percutaneously-exchangeable leaflet set that provides lifetime service without anti-coagulation therapy
  • Company 444 - Combination ultrasound/electrical stimulation device for skin rejuvenation
  • Company 445 - Multi-pixel x-ray source for enhanced system performance/new capabilities
  • Company 446 - Video integration and equipment management system to enhance the MIS market
  • Company 447 - Detection products for viral/bacterial infections, genetic diseases, mutations, cancers, etc.
  • Company 448 - 1-Painless intradermal drug delivery, 2-GERD diagnostic device, 3-Non-invasive continuous glucose monitoring
  • Company 449 - Biomarker assays for the early detection of cancer
  • Company 450 - Ankle replacement implant for patients with chronic pain/arthritis
  • Company 451 - Silk-based biomaterial platforms for tissue rejuvenation/connective tissue repair
  • Company 452 - Biodegradable synthetic hydrogels for general and specialty surgery use
  • Company 453 - Minimally invasive, single-procedure approach for the repair of cartilage damage/osteoarthritis
  • Company 454 - Particle technologies for the treatment/prevention of chronic respiratory disorders
  • Company 455 - Hands-free internal retractor/internally-anchored laparoscope camera cleaner
  • Company 456 - Minimally invasive devices that improve oxygenation for patients with COPD
  • Company 457 - A unique solution similar to ring annuloplasty/edge-to-edge repair, all in one modality, for mitral valve repair
  • Company 458 - Transdermal/wound dressing/mucosal drug delivery
  • Company 459 - Biomaterials-based medical devices focusing on cardiovascular, metabolic, inflammatory, and fibrotic diseases
  • Company 460 - Single molecule DNA analysis system, with no requirement for prior sequence information/PCR/cloning/probes
  • Company 461 - Dynamic "shape memory" platform to optimize mitral/tricuspid valve repair
  • Company 462 - Unique transcranial magnetic stimulation system that allows direct non-invasive activation of deep brain structures
  • Company 463 - Devices for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
  • Company 464 - Unique spinal implant designed to promote rapid fusion
  • Company 465 - Fast, accurate, and easy-to-use in vitro molecular diagnostic products that rapidly identify infectious pathogens
  • Company 466 - Electrosurgical instruments
  • Company 467 - Minimally traumatic, bone- and cartilage-preserving knee implants and instrumentation
  • Company 468 - Neuromodulation system for both traumatic brain injury (TBI) and stroke
  • Company 469 - Inferior vena cava filters
  • Company 470 - Plastic medical devices for gynecological exams and surgeries
  • Company 471 - Ventricular elastic support therapy for heart failure
  • Company 472 - Kidney stone management device and urethral dilating introducer
  • Company 473 - A minimally invasive device for stomach-reduction surgery consisting of a stapling tool that can be passed down the throat into the stomach
  • Company 474 - Minimally invasive therapy for the treatment of chronic disc pain
  • Company 475 - Advanced detection, staging, endoscopic treatment and follow-up care for acute and chronic lung disease
  • Company 476 - Off-the-shelf implantable allograft tissue to support peripheral nerve repair and regeneration
  • Company 477 - Minimally-invasive percutaneous aortic valve replacement systems
  • Company 478 - Cellular imaging technology, using the Internet to transfer real-time/secure/accurate cellular resolution images
  • Company 479 - Deep brain stimulation (DBS) guidance system
  • Company 480 - Customizable vibration therapy devices to stimulate bone/muscle tissue
  • Company 481 - Cellular therapy device to treat liver disease
  • Company 482 - Treatment for ischemia via stem cell-based therapies
  • Company 483 - Minimally invasive therapies for interventional neuroradiology
  • Company 484 - Drug delivery vehicles that can easily be targeted to specific cell types/disease state tissues
  • Company 485 - Bioabsorbable implants for accurate soft tissue fixation either to apposing soft tissue/to bone
  • Company 486 - Bifurcated stenting
  • Company 487 - Non-intrusive patient-monitoring systems that facilitate timely intervention for cardiac/respiratory deterioration
  • Company 488 - Simple, low-cost infusion pump that contains the IV bag within it
  • Company 489 - Human-based tissue scaffolds
  • Company 490 - Minimally invasive vapor technology to treat emphysema
  • Company 491 - Stent that provides protection from embolic showers during/post-procedure
  • Company 492 - Real-time imaging/image guidance for the operating room
  • Company 493 - Tissue engineering technologies for orthopedic/sports medicine patients
  • Company 494 - Anatomically-driven/minimally invasive spinal products for motion preservation
  • Company 495 - Technologies to treat obstructive sleep apnea and snoring
  • Company 496 - Tibial knee implant for stable fixation to the medial tibial plateau without bone cuts/cement/screws
  • Company 497 - Silicon nitride implants with 3-D structured cancellous ceramic for strong capillary action
  • Company 498 - Tissue repair/surgical mesh systems for soft tissue repair
  • Company 499 - Implant designed to retain motion following the removal of diseased disc and/or bone material in the upper spine
  • Company 500 - Minimally invasive disc augmentation system to repair/rehabilitate an intervertebral disc
  • Company 501 - Intelligent microgels as injectable scaffolds for intervertebral disc repair
  • Company 502 - Hydrogel matrix with applications across multiple specialties
  • Company 503 - Intradiscal arthroplasty device utilizing articulating PEEK-on-PEEK material
  • Company 504 - Next-generation of biomaterials for spinal implants
  • Company 505 - Artificial cervical disc with controlled range of motion in all six degrees of freedom
  • Company 506 - Second-generation, metal-on-metal cervical/lumbar artificial discs
  • Company 507 - Products for nuclear replacement/augmentation, vertebral compression fracture repair, and spinal fusion
  • Company 508 - New unilateral posterior fusion technology
  • Company 509 - Next-generation spinal implants
  • Company 510 - True 3-D imaging to improve evaluation/planning of radiation treatments
  • Company 511 - Disposable devices for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
  • Company 512 - Bioresorbable peripheral/coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty
  • Company 513 - Resonating sensor made out of piezoelectric ceramics that can be miniaturized and is suitable for use in diagnostic equipment
  • Company 514 - Miniaturized ultrasound probe that is easier-to-use/more flexible
  • Company 515 - Medical devices for the osteoarthritis/rhinosinusitis markets
  • Company 516 - Percutaneous mitral valve replacement (PMVR) for Mitral Regurgitation (MR)
  • Company 517 - A platform for minimally-invasive cardiac surgery (MICS) via single-port, subxiphoid access, and an endoscope that reaches any anatomical location, including complex paths, from one single access port
  • Company 518 - Plaque vulnerability biomarkers to detect patients at risk for the development of stroke, myocardial infarction or claudication
  • Company 519 - Minimally invasive surgical procedure intended to reduce the incidence of stroke/thromboembolism associated with atrial fibrillation
  • Company 520 - Miniature intravascular flow augmentation device for every organ that needs temporary change of flow
  • Company 521 - Device to percutaneously repair the mitral valve
  • Company 522 - Non-epigenetic cell reprogramming technology that enables the generation of patient-identical replacement tissue/organs on an as-needed basis
  • Company 523 - Transcutaneous yet needleless drug delivery system for the injection of drugs/vaccines in solid doses
  • Company 524 - Microcatheter and imaging technologies for interventional ophthalmology
  • Company 525 - Miniature patch that dispenses insulin
  • Company 526 - Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
  • Company 527 - Wearable artificial kidney device
  • Company 528 - Products to diagnose/treat dry and wet age-related macular degeneration (AMD) and other chronic diseases involving the alternative complement system
  • Company 529 - Non-invasive measurement of magnetic fields to diagnose functional brain disorders
  • Company 530 - Minimally invasive system for treating long-bone fractures using an intermedullary stent/cement
  • Company 531 - Next-generation/fully-automated/electronically-controlled/self-contained blood glucose system
  • Company 532 - Device to improve drainage following heart, lung, and trauma surgery, as well as other procedures where drainage is critical
  • Company 533 - Second-generation electronic retinal implant to treat blindness due to retinitis pigmentosa
  • Company 534 - Pulsatile perfusion generator technology to greatly enhance the preservation time window and organ transplant quality
  • Company 535 - Small/portable/disposable infusion pump kit to treat post-operative pain more effectively than narcotics
  • Company 536 - Computer-controlled pressure garments for the effective treatment of lymphedema/chronic wound healing
  • Company 537 - Neo-organs/tissues derived from the patient's own (autologous) cells
  • Company 538 - Stent technology for the treatment of atherosclerotic disease at/near bifurcations
  • Company 539 - Gene therapy products for the treatment of inherited/acquired diseases.
  • Company 540 - Non-invasive/fast/accurate diagnostic kits for: fertility, hormones, infectious agents, auto-antibodies, and tumor markers
  • Company 541 - Painless system that improves the appearance of cellulite/relieves minor muscle aches, pain, and spasms/temporarily improves local blood circulation
  • Company 542 - Devices to control bleeding post-hysterectomy/in other cases of pelvic area trauma
  • Company 543 - System to process/concentrate cellular components from autologous bone marrow, including adult stem cells, at the point-of-care and in just 15 minutes
  • Company 544 - Membrane optimization, coatings technologies, and development of polymers for biomedical applications
  • Company 545 - Bioactive glass-ceramic material that offers whiter and less-sensitive teeth while protecting from tooth decay
  • Company 546 - More targeted/accurate radiation of cancer cells with significantly fewer side-effects
  • Company 547 - Handheld/breath-based blood glucose monitor
  • Company 548 - Mesh wrap for permanent implantation around the heart to prevent/reverse the progression of heart failure
  • Company 549 - Next-generation cell-based/tissue-engineered products
  • Company 550 - Extracellular matrix derived from fibroblasts isolated from newborns (NO embryonic stem cells/animal products)
  • Company 551 - Direct/real-time/non-invasive vascular imaging via infrared light to visualize both superficial veins/more deeply-located arteries
  • Company 552 - Advanced, intuitive real-time imaging for abdominal minimally invasive surgery
  • Company 553 - Non-invasive, wearable, watch-sized metabolism measurement system that employs the use of a low-cost proprietary disposable sensor using direct-calorimetry, to accurately measure minute-by-minute caloric expenditures
  • Company 554 - De-cellularized biological scaffolds meant to function like native tissue
  • Company 555 - Wireless ECG monitoring
  • Company 556 - Protective coatings for medical instrumentation to combat bacterial biofilms
  • Company 557 - Advanced trilobal pericardial valve technologies
  • Company 558 - Joint prostheses as an adjunct to laminectomy/laminotomy/neural decompression/facetectomy, in lieu of fusion
  • Company 559 - Rapid DNA-based point-of-care diagnostics
  • Company 560 - Catheter-based drug delivery system designed to dissolve blood clots in a single/rapid/one-step procedure
  • Company 561 - Minimally invasive/flexible spinal implant technology to treat vertebral compression fractures and degenerative disc disease
  • Company 562 - Modified bioactive ceramics and second-generation tissue regeneration smart materials
  • Company 563 - Non-invasive electrocardiographic imaging
  • Company 564 - Third-generation cancer-associated biomarkers using proteomics
  • Company 565 - Technology for real-time identification/localization of cancer cell clusters to enable complete/residual-free therapeutic excisions
  • Company 566 - Catheter-based drug delivery using high-frequency/low-power ultrasound
  • Company 567 - Cerebral protection system to prevent embolic strokes
  • Company 568 - Non-invasive neurorehabilitation system
  • Company 569 - System that enables consistent tissue contact/complete lesions during cardiac surgery for the treatment of arrhythmias
  • Company 570 - More viable/cost-effective method for treating intracranial aneurysms
  • Company 571 - Short-pulsed/plasma-mediated electrosurgical instrumentation that avoids extensive collateral damage
  • Company 572 - Single, multi-cannula laparoscopic port and specially designed curved instrumentation
  • Company 573 - Fluid-controlled accommodating intraocular lens (IOL) to restore vision of youth to middle-aged/elderly individuals
  • Company 574 - Non-invasive/urine-based diagnostic assays for specific cancer types
  • Company 575 - Natural cell-based technologies to restore normal neuron function in the central nervous system
  • Company 576 - Less invasive devices for the treatment of glaucoma, intended to replace current therapies
  • Company 577 - Minimally invasive/RF nerve ablation to reduce of migraine headache pain
  • Company 578 - Implantable patient alerting system for the detection and prevention of heart attacks
  • Company 579 - 3-D tracking devices for use in surgical navigation and MIS
  • Company 580 - Line of antimicrobial coatings to prevent microbial colonization/biofilm formation of endotracheal tubes/other indwelling medical devices
  • Company 581 - Device for the treatment of sudden cardiac arrest for both in- and out-of-hospital markets
  • Company 582 - Non-invasive infrared imaging system for the early detection of breast cancer
  • Company 583 - 1-Percutaneous venous valve, 2-Inferior vena cava filter, 3-Multi-purpose/disposable laparoscopic scissor grasper, 4-Multi-sized/multi-stiffness guidewire
  • Company 584 - Light-activated drug therapy to transform cancer into a treatable chronic disease
  • Company 585 - Technologies that will prevent infection for many large patient populations
  • Company 586 - Disposable laboratory-on-a-card ("lab card") device to deliver sample-to-result analyses in minutes at the point of patient-caregiver contact
  • Company 587 - Biocompatible shape memory polymers which can be programmed to change shapes/rigidity when an initiating stimulus is applied
  • Company 588 - Therapeutic approaches to prevent the abnormal tissue growth that inhibits recovery from surgical procedures/impairs normal wound healing
  • Company 589 - System to inactivate pathogens in all three major blood components: platelets/plasma/red cells
  • Company 590 - Electromagnetic thermal therapy to relieve pain/improve function in patients suffering from osteoarthritis
  • Company 591 - Unique spine functional testing that delivers improved surgical outcomes
  • Company 592 - Robotic system for fabrication of nano-material based wound dressings, delivered on-demand, at the POC
  • Company 593 - Digital image acquisition, coupled with proprietary CAD decision-making algorithms, to provide an immediate/automated colposcopic evaluation
  • Company 594 - Cardiac assist device for patients in moderate/severe long-term heart failure
  • Company 595 - Catheter-based systems that will provide very rapid/selective hypothermia to various body organs and locations
  • Company 596 - Truly minimally invasive or open system utilizing a proprietary uni-axial screw at one-half the cost of poly-axial systems for all spine disorders
  • Company 597 - Non-invasive devices for the treatment of superficial venous disease
  • Company 598 - Medical devices that enable earlier detection/minimally invasive treatment of lung cancer
  • Company 599 - MRI-guided laser ablation system for targeted, minimally invasive, focal tumor therapy
  • Company 600 - System of products that will restore continence control to individuals with abdominal ostomies/eliminate the need for traditional ostomy pouching systems
  • Company 601 - Non-invasive/iontophoretic drug delivery system with broad applicability for treating serious ocular diseases
  • Company 602 - Reliable/accurate/solid-state laser system for customized treatment of many vision disorders
  • Company 603 - Cryotherapy to ablate diseased tissue
  • Company 604 - Non-invasive/convenient measurement and monitoring of human hydration status, using saliva as a sample
  • Company 605 - A soft tissue aperture fixation system for anterior cruciate ligament (ACL) reconstruction using the hamstring/other soft tissue grafts
  • Company 606 - MRI contrast agents to monitor the position/quantity of transplanted cells non-invasively in vivo
  • Company 607 - Applicator for breast brachytherapy that delivers targeted dose of radiation
  • Company 608 - Automated blood analysis at point-of-care
  • Company 609 - Biochips to identify gene expression patterns
  • Company 610 - Technology enabling detection and monitoring wirelessly, remotely, and with no contact to the subjects; also through clothing/barriers
  • Company 611 - Phototherapy/ultraviolet light to inactivate the organisms that cause nail infections
  • Company 612 - Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema
  • Company 613 - Soft tissue repair/replacement, using proprietary chemistry and organic collagen matrices
  • Company 614 - Next-generation personal diagnostics for hematological malignancies/autoimmune disorders
  • Company 615 - Advanced method of photocoagulation to provide more rapid, precise, and safe treatment for a variety of retinal conditions
  • Company 616 - Diagnostic and therapeutic catheter-based devices for prevention/treatment of heart attacks caused by soft plaque
  • Company 617 - Very strong/customizable/biomimetic/easily revisable artificial disc implant, requiring no assembly in situ
  • Company 618 - Real-time endoscopic tissue imaging system for high-resolution visualization of bronchial/pulmonary tissue cross-sections without biopsy
  • Company 619 - Next-generation transluminally placed endovascular grafts for the treatment of aneurysmal disease in the AAA/TAA
  • Company 620 - Cellular therapy to act directly at the level of the cause of autoimmune disorders, the dysregulated immune regulation
  • Company 621 - 3-D/single-piece/dual optic accommodating intraocular lens (IOL)
  • Company 622 - Non-invasive method designed to only kill fat cells and not harm the skin or other tissue
  • Company 623 - Non-invasive technique for sampling the surface layers of the skin to generate individual genetic profiles for diagnostic/prognostics
  • Company 624 - Therapeutic gene delivery to treat diabetes/obesity/intestinal disorders/hemophilia/anemia
  • Company 625 - Flexible/single-use/sterile video-endoscopes which may be used at the patient bedside and which avoid all cross-contamination risks
  • Company 626 - Biomotion sensors that enable easy/non-contact capture of high-quality physiological data - remotely/wirelessly
  • Company 627 - Stent to treat cerebral/aortic aneurysms by modulating hemodynamic flow
  • Company 628 - One-shot, instantaneous anastomotic stapling devices for open AAA, EVAR, and CLI applications
  • Company 629 - Device that uses combined electric field and low-intensity, noninvasive ultrasound for the treatment of solid tumors without the need for chemotherapy
  • Company 630 - Beam steering/target tracking/treatment planning solutions to the external beam radiation therapy market
  • Company 631 - Full line of precision-crafted/disposable/ultra-minimally invasive surgical instruments
  • Company 632 - Technology that selectively treats only cancer cells and avoids destruction of normal cells
  • Company 633 - Artificial muscle technology for the treatment of faecal and urinary incontinence
  • Company 634 - Matrix therapy based technology that treats skin ulcers/reduces amputation
  • Company 635 - Guidewire system intended to safely/quickly cross occluded peripheral and coronary vessels
  • Company 636 - Noninvasive tests for the risk assessment of cardiovascular disease and the detection of early-stage lung/breast/colorectal cancer
  • Company 637 - Implanted electronic subretinal device to restore vision to those who are blind due to retinitis pigmentosa (RP) or age-related macular degeneration (AMD)
  • Company 638 - Bioresorbable polymer surgical implants designed to prevent/reduce the formation of post-operative adhesions
  • Company 639 - Percutaneous soft tissue lifts for the breast/neck/other soft tissue structures
  • Company 640 - Ultrasonic energy for the selective dissection/fragmentation/debridement/cleansing of tissues
  • Company 641 - Single-use catheter device w/controller that delivers radiofrequency energy during outpatient bronchial thermoplasty for the treatment of asthma
  • Company 642 - Aortic valve bypass graft system for use as a minimally invasive, beating heart alternative to traditional aortic valve replacement therapy
  • Company 643 - Recombinant adeno-associated viral (AAV)-based gene therapy as a treatment for congestive heart failure (CHF)
  • Company 644 - Low-dose-rate brachytherapy that will replace individual seeds and provide more uniform/consistent radiation delivery to patients
  • Company 645 - Affordable/good quality standard-of-care surgical devices
  • Company 646 - Non-contact imaging system that provides local anatomical and oxygenation information
  • Company 647 - Light-activated glue system to stabilize shattered bone
  • Company 648 - In situ formed hydrogels designed/indicated for ophthalmic surgery
  • Company 649 - Surgical implants and biological products for spinal surgery
  • Company 650 - Digital pump with no mechanical parts for drug delivery/infusion therapies
  • Company 651 - Ultra-lightweight/soft/non-palpable mesh technology to treat urinary stress incontinence/pelvic organ prolapse
  • Company 652 - Real-time/PCR-based molecular diagnostic tests for life-threatening respiratory fungal infections
  • Company 653 - CO2 lasers through flexible/rigid endoscopes for use in minimally invasive surgery and soft tissue procedures in otolaryngology/head and neck surgery/pulmonology
  • Company 654 - Interspinous/interlaminar functionally dynamic stabilization device and other non-fusion scoliosis technologies
  • Company 655 - Temperature-controlled/multi-functional next-generation cutting/sealing product
  • Company 656 - Non-invasive intracranial pressure monitor to diagnose/treat head injury
  • Company 657 - Cobalt-chromium, balloon-expandable stent, which marries with approved DES to treat the entire spectrum of coronary artery bifurcation lesions
  • Company 658 - Non-invasive gene expression-based tests for the monitoring of transplant rejection/autoimmune diseases
  • Company 659 - Lightweight brace support suit that restores mobility function for paraplegics/lower limb paralysis patients
  • Company 660 - Hand-held ultrasound device to quantify strain and stiffness of tendons/ligaments
  • Company 661 - Portable/palm-held endoscopic imaging with a mobile platform for recording/sharing/archiving images
  • Company 662 - Injectable gels for localized and controlled release of biologicals
  • Company 663 - 3-D scaffold that enhances the biointegration of percutaneous/fully implanted current and next-generation devices
  • Company 664 - Wireless/motorized orthopedic lengthening implants for applications in deformity correction/cosmetic limb lengthening/bone fractures
  • Company 665 - Heart rate variability (HRV) analysis for quantitative assessment of the autonomic nervous system (ANS)
  • Company 666 - Nanotechnology surface treatments for combination medical devices that address nosocomial (in-hospital) infections and thrombus
  • Company 667 - High-resolution dermoscopy imaging technology to identify melanoma at an earlier stage/reduce the number of unnecessary excisions
  • Company 668 - Less invasive approach for mitral valve repair, on a beating heart
  • Company 669 - Minimally invasive interstitial laser therapy (ILT) as an alternative to breast surgery
  • Company 670 - Anti-infective compounds designed to mimic host defense proteins, but with completely synthetic/non-peptide backbones
  • Company 671 - Sutureless anastomosis systems to reduce/eliminate cross clamping time and suturing during minimally invasive surgery (MIS)
  • Company 672 - Systems using radiofrequency (RF) energy for the treatment of GERD and fecal incontinence (FI)
  • Company 673 - Disposable endoscopic assist device that can be used with existing equipment to significantly improve flexible endoscopy procedures
  • Company 674 - Synthetic graft/stent technology that reduces neo-intimal hyperplasia (NIH) and occurrence/rate of restenosis
  • Company 675 - Technology for diagnosing breast and ovarian cancers and determining responsiveness to new therapeutics
  • Company 676 - Simultaneous testing of sobriety and identy that is simple/rapid/non-invasive, requiring no bodily fluids
  • Company 677 - 1-Image analysis technology for virus detection/analysis, 2-Antiviral drugs
  • Company 678 - Light-based aesthetic systems that are pain-free/seven times faster than existing systems
  • Company 679 - Low-level laser technology for aesthetics, bone healing, neck/shoulder pain, and wound healing
  • Company 680 - Single device for high-frequency ultrasound imaging/therapeutic treatment
  • Company 681 - Technologies to: 1-Treat the progression of age-related macular degeneration (AMD) and retinitis pigmentosa (RP), 2-Stop/reverse some of the vision loss from Glaucoma, 3-Prevent diabetic retinopathy, 4-Greatly enhance pars plana vitrectomy surgery
  • Company 682 - Thin-walled/removable/entirely covered stents designed to match the site to be treated and the surrounding anatomy
  • Company 683 - Cells derived from bone marrow which can be used in an allogeneic/off-the-shelf setting to treat kidney/other difficult to treat diseases
  • Company 684 - Endovascular treatment of peripheral arterial blood vessels that require re-vascularization
  • Company 685 - Radiofrequency (RF) energy to reshape the cornea without incision
  • Company 686 - Synthetic peptides for tissue regeneration for the treatment of musculoskeletal/vascular/chronic wound diseases
  • Company 687 - 1-Handheld intelligent bone sculpting tool, 2-X-ray vision that appears "within" the patient
  • Company 688 - Leadless/subcutaneously implantable cardiac defibrillator (ICD)
  • Company 689 - Polymer technologies for cardiac/cranio-maxillofacial/orthopedic surgery applications
  • Company 690 - Implantable device to treat high blood pressure that cannot be controlled with medications/lifestyle modifications
  • Company 691 - Mental stimulation system to help maintain mental acuity/quality of life
  • Company 692 - Technologies to acquire/process/visualize data from 3-D breast imaging
  • Company 693 - Leadless/implantable pacing device for left ventricular stimulation/the treatment of heart failure
  • Company 694 - Less invasive treatment for chronic sinusitis delivered via non-nasal access
  • Company 695 - Device with bio-active formulae to rapidly/painlessly treat/control the wound environment
  • Company 696 - DNA-based diagnostic tests for early identification/management of cancer/acute diseases
  • Company 697 - Ultra-thin/personalized/single-use/flexible/transdermal drug delivery patch
  • Company 698 - Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) device for patients being treated for heart attacks/in heart failure
  • Company 699 - Next-generation coatings/advanced drug-delivery systems for cardiovascular stents and other implantable medical devices
  • Company 700 - Implantable/battery-less diagnostic system to allow orthopedic surgeons to monitor spinal fusion progress
  • Company 701 - Blood screening tests for breast and ovarian cancers
  • Company 702 - Dynamic/intelligent ophthalmic lenses that automatically/electronically adjust focusing power
  • Company 703 - Next-generation Spinal Cord Stimulation (SCS) technology to treat chronic back/lower extremity pain
  • Company 704 - Transpedicular/minimally invasive approach to vertebral body reconstruction/anterior spinal column support
  • Company 705 - Enhanced diabetes insulin pump
  • Company 706 - Handheld/at-home hair removal via laser
  • Company 707 - Nanomaterial-based MRI coil for higher image quality/faster scan times
  • Company 708 - Device that delivers a low-level/precisely controlled heat for the treatment of acne
  • Company 709 - Devices for the destruction of pathogens responsible for: heart/blood/respiratory/gastrointestinal/peridontal/otological diseases, pancreatic cancer, and toe nail fungus
  • Company 710 - Non-invasive type 2 diabetes and pre-diabetes screening with no blood draw/no fasting/no waiting for a lab result
  • Company 711 - Collapsible titanium-alloy implant for spinal fusion
  • Company 712 - Transitional in vivo imaging
  • Company 713 - Technology to close incisions made during Natural Orifice Transluminal Endoscopic Surgery (NOTES) procedures
  • Company 714 - Molecular imaging of apoptosis (programmed cell death) for disease detection/monitoring
  • Company 715 - Resurfacing system to treat lesions/defects in the body's weight bearing, non-weight bearing, and extremity joints
  • Company 716 - Simple, point-of-care blood test for the detection/monitoring of traumatic brain injury (TBI)
  • Company 717 - Miniature implantable neurostimulator for treating central nervous system disorders
  • Company 718 - 1-Vertebral augmentation system and 2-On-demand ultra-high viscosity cement injection, for spinal applications
  • Company 719 - Therapeutic gene delivery
  • Company 720 - Rapid, point-of-care diagnostic tests for periodontitis/group A strep/systemic fungal infections, capable of detecting virulence markers produced ONLY during active infections
  • Company 721 - Totally implantable pumps delivering targeted medications directly to the spinal cord
  • Company 722 - Next-generation femtosecond laser that can operate inside the eye to make cataract surgery safer/more effective
  • Company 723 - Optical Coherence Tomography (OCT) for sub-surface biological tissue imaging at much greater resolution than ultrasound/MRI/CT scanners
  • Company 724 - Percutaneously deliverable endograft to treat Abdominal Aortic Aneurysms (AAA) and Thoracic Aortic Aneurysms (TAA)
  • Company 725 - Atraumatic injectable plugs for 1-Temporary occlusion of blood vessels, 2-Kidney stone removal, and 3-future applications
  • Company 726 - Technology for the non-fusion treatment of scoliosis
  • Company 727 - 1-Soft/disposable contact lens with embedded MEMS sensor for continuous intraocular pressure (IOP) monitoring in glaucoma patients, 2-Telemetry solutions for implantable medical devices
  • Company 728 - Plastic surgery implantable devices for cosmetic and reconstructive surgery
  • Company 729 - Painless photo-pulsation technology for diminishing fine lines/wrinkles/age spots on the face/neck/hands
  • Company 730 - 3-D mesh pouches that are implanted empty, positioned, filled, then deployed to their full size for spinal/orthopedic applications
  • Company 731 - Minimally invasive system to treat emphysema and resolve prolonged air leaks following lung surgery
  • Company 732 - Next-generation respiratory device that delivers synchronization of flow/temperature/humidity/oxygen percentage, without discomfort, via nasal cannula
  • Company 733 - Percutaneous interventional devices to treat common spinal diseases, such as lumbar spinal stenosis
  • Company 734 - Electronic brachytherapy that delivers non-isotope-based/localized/targeted radiation
  • Company 735 - Diagnostic instrument to measure the material properties of bone
  • Company 736 - Wireless/MEMS-fabricated/nano-processed/dermal/percutaneous continuous glucose monitoring device
  • Company 737 - Technologies that focus on wound diagnostics, infection control, and wound therapy
  • Company 738 - Affordable, simple-to-use means of self-monitoring women's reproductive status for: conception, birth control, ovulation, and cervical cancer screening
  • Company 739 - 1-Next-generation, natural fibrin sealant, 2-Human thrombin
  • Company 740 - Wireless/disposable sleep-monitoring device
  • Company 741 - Custom miniaturized mechanical components/devices for a broad range of medical device applications
  • Company 742 - 1-Non-embryonic cell technology that creates cells/tissues/organs for virtually anyone needing a transplant, 2-Non-toxic cancer vaccine that uses the body's natural immune response to fight cancer, 3-Cell separation system to diagnose/monitor cancer
  • Company 743 - Wearable mobile device to accurately measure real-time energy (calorie) expenditure/combat obesity
  • Company 744 - True seizure "prediction" - up to an hour before the event
  • Company 745 - Real-time imaging for "dying" heart/brain/other tissue - non-invasive/non-radioactive/non-toxic
  • Company 746 - In vivo transdifferentiation to regenerate ischemic/diseased organs
  • Company 747 - Real-time/in vivo/cellular-level/3-D imaging for: image-guided surgery; early cancer diagnosis without a biopsy
  • Company 748 - Coating that triggers the body to generate nitric oxide (NO) at the device surface, by using naturally circulating blood substances
  • Company 749 - Convenient/improved continuous glucose monitoring system
  • Company 750 - Manual rongeur and access tools for use in spinal decompression procedures
  • Company 751 - Miniature implantable sensors to accurately/continuously pinpoint the location of tumors in real-time, during radiation therapy delivery
  • Company 752 - Laparoscopic instruments that articulate/rotate/lock for single port access/"scar-less" surgery
  • Company 753 - 1-Needleless mesotherapy to treat cellulite, 2-Non-invasive/non-thermal treatment for skin laxity/hypertrophic scars/striae
  • Company 754 - Effective/consistent/non-invasive neuromodulation for the treatment of urinary incontinence and future applications
  • Company 755 - Minimally invasive surgery system for simpler and safer soft-tissue suturing/fastening
  • Company 756 - Technology that restores natural physiologic outflow as a foundation of significant/steady/sustained glaucoma management
  • Company 757 - Home-use devices for hair removal/acne/skin rejuvenation
  • Company 758 - Implantable neuromodulation device for the treatment of chronic pain and future applications
  • Company 759 - Ocular metabolic imaging to "predict" eye diseases, including diabetic retinopathy/glaucoma/age-related macular degeneration
  • Company 760 - Gene expression test for the diagnosis of ambiguous tumors
  • Company 761 - Minimally invasive device to treat emphysema
  • Company 762 - Counter-stimulation technology to treat Restless Legs Syndrome (RLS)
  • Company 763 - Ingestible/wireless capsule with sensor technology to measure pH, pressure and temperature from within the entire GI tract
  • Company 764 - Synthetic scaffold to aid soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee
  • Company 765 - Dental implant that can be placed into a multi-rooted molar extraction site "immediately"
  • Company 766 - Disposable/miniature/minimally invasive surgical devices including reusable endoscopes for visualization, initially for use in spinal surgeries
  • Company 767 - Tests to "predict" chronic diseases/conditions, such as diabetes/osteoporotic bone fracture/a major cardiac event
  • Company 768 - Technology to treat atrial fibrillation that allows doctors to perform radiofrequency ablation under direct visualization
  • Company 769 - Intraoperative wavefront aberrometer for use in intraocular lens replacement surgeries
  • Company 770 - Technology for wound care and slow release drug delivery, by both transdermal and subcutaneous routes
  • Company 771 - Optimization of T cell receptors (TCRs) for use in adoptive T cell therapy - to target and destroy cancerous/infected cells
  • Company 772 - Autonomic nervous system stimulation for pulmonary and headache disorders
  • Company 773 - Endoscopically delivered devices focused on slowing gastric emptying, to treat all stages of obesity
  • Company 774 - Neurostimulator for cardiac contractility
  • Company 775 - Simple, rapid, blood-based cancer tests to provide accurate and individualized clinical information on disease status/treatment selection/treatment response
  • Company 776 - Coagulation analyzer to eliminate unnecessary blood transfusions
  • Company 777 - 1- Straightforward knotless suture anchor, 2-Instrumentation for percutaneous suture management, 3- Endotendonous repair system, 4-Shape memory staples
  • Company 778 - Implantable device for maintaining adequate blood flow to the brain in patients experiencing a buildup of excess cerebral spinal fluid (CSF) due to trauma
  • Company 779 - Platforms for: 1- Pedicle screw fixation (even with poor bone quality), 2-Vertebral compression fractures, 3-Simple- to-use trauma products
  • Company 780 - Joint reconstruction device that ideally/anatomically matches the size/shape of the facet joint
  • Company 781 - Wireless/wearable/ultra-compact device that automatically tracks/wirelessly uploads data about a person's activities (exercise intensity levels, calories burned, sleep quality, steps, distance)
  • Company 782 - Painless, continuous glucose monitoring
  • Company 783 - System that assesses, then provides therapy to develop infant feeding skills
  • Company 784 - Behavioral remote patient monitoring system that uses wireless sensors to non-intrusively track and report on the daily patterns of seniors' activities
  • Company 785 - Drug-coated balloon angioplasty technology
  • Company 786 - Early detection of Alzheimer's disease via an eye drop and laser eye scan
  • Company 787 - 1-Prohealing coronary stent as an alternative to drug-eluting stents (DES), 2-Balloon -expandable/crush-resistant nitinol peripheral stent, 3-Nano-based transcatheter, 4-Anatomy-specific combination embolic protection and stent delivery systems, 5-Localiz
  • Company 788 - 1-Artificial vascular graft with self-sealing, non-woven, synthetic fiber structure, 2-Ventral hernia mesh
  • Company 789 - Orthopedic imaging
  • Company 790 - Vertebral compression fracture treatment
  • Company 791 - Next- generation/predictive blood tests to help warn of potential future health problems
  • Company 792 - A1c diabetes testing at the point of care, with results in under 4 minutes
  • Company 793 - Technology that allows surgeons to rapidly treat tissue at the surgical site/reduce blood loss
  • Company 794 - Percutaneous injection treatment for patients with internal disc derangement (IDD) who have failed conservative care/are not yet candidates for total disc replacement (TDR)/spinal fusion
  • Company 795 - Portable/lab-quality diagnostics for the ER/ambulance/physician's office/home/field
  • Company 796 - Permanent implant to address mitral regurgitation directly
  • Company 797 - Compact, remote, wireless, real-time device for biomedical monitoring such as cardiac, neurological, sleep disorder, obstetrics, orthopedic, and other vital signs outside the hospital/clinic
  • Company 798 - Injectable porous scaffolds/spheres/composites with fully interconnected pores, for multiple applications
  • Company 799 - Non-invasive devices to identify patients with coronary artery disease (CAD) and other life-threatening cardiovascular conditions
  • Company 800 - Next-generation endovascular devices that incorporate advanced fiber optics technology into currently used products/procedures to improve patient outcomes without adding to procedure time/cost
  • Company 801 - Technologies that integrate bone and cartilage forming peptide and small molecule therapies with osteostimulating matrices
  • Company 802 - High-dose drug delivery system for the minimally invasive and repeatable treatment of liver cancers, colorectal cancer, and hepatitis
  • Company 803 - Non-invasive/fast/easy-to-use/reliable medical devices that test for neuro-visual disorders
  • Company 804 - Resorbable hydrogel that 1-Seals annular tears in the intervertebral disc and 2-Provides an environment for nucleus regeneration
  • Company 805 - Technology used in: 1-Finished products designed for micro-surgical/microscopy procedures and robotics and 2-Biosensors with applications in gene expression, neuroscience, and nanotechnology
  • Company 806 - Monitoring products/clinical services for advanced ambulatory cardiac monitoring
  • Company 807 - Catheter ablation for the treatment of cardiac arrhythmias
  • Company 808 - Endoscopically implantable devices for weight loss/to control Type 2 diabetes
  • Company 809 - Ocular scanner for rapid/non-invasive triage and detection of pre-symptomatic conditions including exposure to toxins, presence of systemic diseases, and indication of internal injury
  • Company 810 - Fluorescent markers/optical sensors that provide an accurate and rapid determination of kidney function
  • Company 811 - Low-cost/point-of-care (POC) analyzer to quantify hemostasis in whole blood, including cellular and plasma components
  • Company 812 - Next-generation computer-assisted laparoscopic tool composed of multiple rigid elements with intervening controllable joints
  • Company 813 - Electroporation-delivered/DNA-based vaccines against cancers and infectious diseases
  • Company 814 - Effective and convenient phototherapy system available for in-home treatment of scalp/small-area psoriasis and other photo-responsive skin diseases
  • Company 815 - Natural polymer technology that mimics the physiological clotting cascade without reliance on blood-derived proteins - to stop severe bleeding, reinforce staple and suture lines, and repair tissues
  • Company 816 - Non-invasive molecular diagnostics for autism, chronic obstructive pulmonary disease (COPD), multiple sclerosis, and diseases with a genetic susceptibility
  • Company 817 - Smart, accurate guiding device based on image technology for orthopedic trauma procedures such internal fixation with intramedullary (IM) nails, osteotomy, and others
  • Company 818 - Wireless neurostimulation device to treat refractory chronic pain - 100 times smaller than current technology and injectable via a minimally invasive hypodermic needle
  • Company 819 - Biomarkers for the screening and diagnosis of cervical and other cancers
  • Company 820 - Wearable health monitoring system for potential diabetes, heart disease, and sleep apnea applications
  • Company 821 - Pocket-sized, affordable, and easy-to-use resuscitation devices that can be effectively deployed by both trained professionals and laymen
  • Company 822 - 1-Pacing/sensor-enabled device for Cardiac Resynchronization Therapy (CRT), 2-Real-time modality to quantify cardiac performance, 3-System that adds ingestible microchips to drugs
  • Company 823 - Nasal stent to treat obstructive sleep apnea
  • Company 824 - Molecular diagnostic tests to: 1-Differentiate between squamous and non-squamous non-small-cell lung cancer, 2-Differentiate between mesothelioma and adenocarcinoma, 3-Identify more than 20 types of cancer
  • Company 825 - Real-time interactive training visualization system, specifically for the task of training any designated personnel in successfully accomplishing a limited "focused assessment with sonography for trauma" (FAST) examination
  • Company 826 - Continuous glucose monitoring specifically for use in the Intensive Care Unit (ICU)
  • Company 827 - Minimally invasive/endoscopically-placed device to treat obesity by inducing satiety in the esophageal/cardiac portion of the stomach
  • Company 828 - Non-invasive biomechanical diagnostic system that records/analyzes range of motion (ROM) in a full 3-D environment for musculoskeletal diagnostics/therapeutics
  • Company 829 - Ultrasound-based diagnostic biosensor that enables blood analysis at the molecular level for the patient self-testing market
  • Company 830 - Polymer-based/biodegradable/drug-eluting peripheral vascular stent for tibial and infrapopliteal arteries
  • Company 831 - Real-time/multi-user image communication/collaboration system that consolidates images and text records into a single point of access
  • Company 832 - Technology that uses the patient's own blood to make either: 1-A surgical sealant to prevent/stop bleedings or 2-A gel to stimulate the healing of chronic wounds
  • Company 833 - Femtosecond pulse laser system for various ophthalmic applications
  • Company 834 - Cyanoacrylate-based products for wound care and infection prevention
  • Company 835 - Nanotechnology-based liquid that absorbs energy on a near-molecular scale versus relying on the mechanical properties of solid materials
  • Company 836 - Tool for early diagnosis of age-related macular degeneration (AMD)
  • Company 837 - Heart valve implant
  • Company 838 - Fully implantable device for the treatment of central sleep apnea in heart failure patients
  • Company 839 - Permanently implantable/wireless/miniature sensors to transmit cardiac output, blood pressure, and heart rate data
  • Company 840 - Artificial heart made of biosynthetic tissues, with two-pumps
  • Company 841 - Small shunt-like device implanted into the bloodstream to modify, collect, or eliminate a broad range of Target Cells
  • Company 842 - Disposable and needleless patch that can be placed on the body inconspicuously for insulin delivery
  • Company 843 - Biomaterial with exceptional hardness/low friction/bio-inertness that also prevents the leaching of metallic ions into the body
  • Company 844 - Products for coronary bypass, valve repair and replacement, cardiac ablation, and heart failure surgery
  • Company 845 - A monthly, rapid test to accurately monitor and potentially diagnose Diabetes
  • Company 846 - Catheter insertion systems, designed for extended IV dwell time, to eliminate the risk of related bloodstream infections
  • Company 847 - Cooling and compression therapy for the relief of pain/swelling after orthopedic/other surgery
  • Company 848 - Invisible hearing device
  • Company 849 - Next-generation implants, stem cell enabling technology, and other minimally invasive surgical instruments
  • Company 850 - Implantable neuromodulation device designed to electrically alter the pain signal pathways
  • Company 851 - Non-systemic/non-invasive system that delivers magnetic versus electrical pulses for the treatment of depression
  • Company 852 - Electrodes/neural interface products for functional neurosurgery and neurostimulation
  • Company 853 - Polymer implant to repair meniscal tears via tissue regeneration
  • Company 854 - Andara technology for the treatment of acute spinal cord injury
  • Company 855 - Device for the treatment of benign prostate hypertrophy (BPH), prostatitis, erectile dysfunction (ED), lower urinary tract symptoms, and infertility
  • Company 856 - Next-generation "permanent" biomaterial to reduce the risk of infection/thrombosis/restenosis
  • Company 857 - Spine fusion implant for motion preservation/dynamic stabilization
  • Company 858 - Spine implant that allows for post-operative adjustment of the implant size via radio control
  • Company 859 - Minimally invasive spine implant (facet versus pedicle screw)
  • Company 860 - Next-generation nanostructured capacitors for: 1-implantable cardiac defibrillators (ICD) and 2-microsteerable cardiac ablation and related catheters
  • Company 861 - Ultrasound system that can measure true tissue elasticity in a reproducible/quantifiable/user-independent manner
  • Company 862 - Tissue fusion via infrared laser to replace sutures
  • Company 863 - Minimally invasive neurosurgical and orthopedic instruments and implants
  • Company 864 - Next-generation needleless drug delivery
  • Company 865 - 1-Minimally invasive treatment of spinal compression, 2-Minimally invasive treatment of long bone factures, 3-Neuromodulation catheter that can be introduced into the spinal canal to treat pain
  • Company 866 - Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord injury
  • Company 867 - Aortic embolic protection device for acute and long-term use
  • Company 868 - Allogeneic cell therapy derived from the human placenta to mimic the natural environment of bone marrow
  • Company 869 - Endoscopic device to treat sinusitis
  • Company 870 - System to repair abdominal aortic aneurysms (AAA)
  • Company 871 - Neuromodulation for hypertension/heart failure
  • Company 872 - Endoscopy system to improve the detection of polyps in the colon
  • Company 873 - Tests for the diagnosis/prognosis of cardiovascular disease
  • Company 874 - Portable/rapid cooling technologies via the nasal cavity to improve patient outcomes after cardiac arrest, stroke, or traumatic brain injury (TBI)
  • Company 875 - Bone graft material that is: 1- synthetic, 2-non-immunogenic, 3-inclusive of all bone regenerative properties of an autograft, and 4-cost-effective
  • Company 876 - Cancer diagnostic test which enables the development of personalized therapeutics
  • Company 877 - Artificial heart technologies
  • Company 878 - Mechanical thrombectomy device to treat ischemic stroke
  • Company 879 - Compliant balloon platform technology for use in neuroradiology, cardiovascular, and peripheral vascular applications
  • Company 880 - Inferior vena cava (IVC) filter that includes: 1-automatic self-centering, 2-bi-directional deployment and retrieval, 3 -atraumatic design, and 4-total transluminal filtration
  • Company 881 - Easy-to-use/automated/rapid detection of severe infectious diseases
  • Company 882 - Diagnostic retinal imaging system for use in the primary care setting
  • Company 883 - Wearable display technology to restore quality of life for those suffering from age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and retinitis pigmentosa (RP)
  • Company 884 - Device for removing uterine fibroids without hysterectomy
  • Company 885 - Non-woven fabric with extended shelf-life to restore/repair tissue function
  • Company 886 - Variety of diagnostic tests for infectious diseases, cardiology, hepatology, and various cancers
  • Company 887 - Non-polymeric drug-eluting stent (DES)
  • Company 888 - Minimally invasive implant for treating spinal stenosis
  • Company 889 - Device to treat osteoarthritis
  • Company 890 - Molecular diagnostic/prognostic tests for cancer
  • Company 891 - Surgical/restorative dental implants
  • Company 892 - Non-invasive neurostimulation device to restore vision to patients suffering from stroke, traumatic brain injury (TBI), dry age-related macular degeneration (AMD), and glaucoma
  • Company 893 - Nanomaterials for angiogenesis/anti-angiogenesis/diagnostic applications
  • Company 894 - Diagnostic and therapeutic ophthalmic devices
  • Company 895 - Computer-assisted surgical devices for total joint replacement
  • Company 896 - DNA sequencing technology for the detection of biomarkers for infectious and other diseases
  • Company 897 - Heart pump technologies
  • Company 898 - Non-invasive DNA-based prenatal diagnostic test
  • Company 899 - Lightweight, waterproof, medical alert pendant for seniors - to avoid the dangers of missed medications
  • Company 900 - Minimally invasive breast tumor diagnosis and treatment
  • Company 901 - Peripherally inserted central catheter (PICC) that utilizes a sensor technology with handheld device for self-guided insertion
  • Company 902 - Wearable sensor technology that safely and accurately measures individual sleep patterns
  • Company 903 - Devices to treat low back pain
  • Company 904 - Non-invasive diagnostic prenatal testing via maternal blood test
  • Company 905 - 1-Bioactive/conductive polymer materials and coatings for implantable biomedical devices and 2-Next-generation all-polymer leads that may be grown in the body
  • Company 906 - Computer-controlled rehabilitation table for the management of lower back pain
  • Company 907 - Wearable neuroimaging cap for mapping brain function
  • Company 908 - Comfortable, soft, and pliable cloth mask for the treatment of obstructive sleep apnea
  • Company 909 - Minimally invasive therapy for Emphysema
  • Company 910 - Microarray-based technology enabling targeted next-generation sequencing of genomic regions of interest
  • Company 911 - Imaging systems for the non-invasive, in vivo detection of cancerous and pre-cancerous lesions
  • Company 912 - "Smart" cells than can determine the type of disease/injury present in the body and repair/regenerate tissue accordingly
  • Company 913 - Endoscopic/removable device that mimics the effects of gastric bypass surgery on a patient's metabolism
  • Company 914 - Non-invasive vascular disease detection that combines the advantages of MRI with the temporal resolution and ease-of-use of ultrasound
  • Company 915 - Non-invasive breast cancer diagnostic test via breast fluid analysis
  • Company 916 - Molecular diagnostic technologies for organ transplantation and various complex genetic disorders
  • Company 917 - Biomarker discovery platform for detecting Type 2 Diabetes, Prostate Cancer, and Amyotrophic Lateral Sclerosis (ALS, aka Lou Gehrig's disease)
  • Company 918 - Targeted molecular assays for onco-diagnostics/personalized medicine
  • Company 919 - Catheters for dissolving/removing cerebral blood clots then delivering therapeutics to the diseased site
  • Company 920 - New holding company for various orthopaedic device companies, such as Enztec and OMNI life science
  • Company 921 - Optical biopsy needle that will accurately diagnose prostate cancer, yet eliminate random prostate biopsies
  • Company 922 - Minimally invasive radiofrequency (RF) device to treat aging skin
  • Company 923 - Endoscopically placed device for the treatment of obesity
  • Company 924 - Lab-free salt intake monitor for hypertension/congestive heart failure (CHF) patients
  • Company 925 - Instrumentation that provides surgeons with real-time sensing/feedback from the operative site
  • Company 926 - Technology that enables the "packaging" of chronic therapies/biologics in an easy-to-use, disposable patch-like device
  • Company 927 - Pneumatic compression devices targeted to the lymphedema, venous insufficiency, and sports medicine markets
  • Company 928 - Next-generation vessel closure
  • Company 929 - Visually guided catheter ablation for atrial fibrillation
  • Company 930 - Communication device that acquires neurological signals from the brain and translates them into speech
  • Company 931 - Wireless device for the treatment of stress/urge/mixed urinary incontinence (UI)
  • Company 932 - Invisible/battery-less hearing device that is permanently implanted, yet completely reversible and MRI-compatible/safe
  • Company 933 - Injectable biopolymer for the direct treatment of acute myocardial infarction (AMI)
  • Company 934 - Next-generation anatomic pathology (AP) with improved speed, automation, and ease-of-use
  • Company 935 - Highly porous resin that broadly removes toxins related to sepsis from blood
  • Company 936 - Implantable replacement valve to treat incompetent deep vein valves causing degenerative pain, swelling, and non-healing ulcers associated with chronic venous insufficiency (CVI)
  • Company 937 - Non-invasive ophthalmic medical devices for: 1-diabetes screening and 2-daily glucose monitoring
  • Company 938 - 1-System for remote home patient monitoring of glucose, blood pressure, and thermal weight, 2-Glucose meter cell phone
  • Company 939 - Non-surgical/injectable tissue revitalization and stabilization to address lower back pain (LBP) and the underlying problem of mechanical insufficiency
  • Company 940 - Extracellular matrix (ECM) implant that is completely integrated, remodeled, and replaced by the patient’s native tissue over time
  • Company 941 - Technology that precisely eliminates irregularly shaped/invasive solid tumors while avoiding significant damage to surrounding healthy tissue and is non-toxic
  • Company 942 - Systems to diagnose neurological and sleep disorders
  • Company 943 - Accommodative intra-ocular lens (IOL) technology to treat cataracts/presbyopia/impaired vision
  • Company 944 - 1-Biopsy needles with enhanced ultrasound visualization, 2-Microencapsulated tissue markers, 3-Cryo-chemoablation of tumors
  • Company 945 - Nanolayer surface technology to improve the osteoconductive/bio-resistant/anti-infective attributes of implants
  • Company 946 - Surgical instrument designed to solve recurrent problems in managing sutures, tissue reattachment, and visualization during surgical procedures
  • Company 947 - Non-invasive neuromodulation platform technology
  • Company 948 - Electrical stimulators via electrode garments for the treatment of pain related to chronic/acute soft tissue injuries
  • Company 949 - IV safety system with real-time, disposable \"smart\" sensors
  • Company 950 - Permanently implanted electrical neural stimulators to treat balance/hearing/perceptual disorders
  • Company 951 - Wireless/battery-less antenna on a chip (tag) for continuous tracking of blood samples
  • Company 952 - Intelligent 3DHD visualization and guidance platform for ophthalmic, cranial, and spine surgeries
  • Company 953 - Percutaneous anastomosis device for vascular access
  • Company 954 - 1-Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures, 2-Low profile single-patient-use tissue retractor, 3-Range of 7Fr intra aortic balloon catheters with fluid-filled technology that plugs into current hardware
  • Company 955 - Therapy delivery platform for the upper airway with applications to initially target chronic sinusitis, nasal allergies, cystic fibrosis, and CPAP users
  • Company 956 - Mobile air purification unit that captures and destroys airborne pathogens
  • Company 957 - Functionalized injectable biopolymers for medical applications
  • Company 958 - Therapeutic substances for bone regeneration
  • Company 959 - Precision stapling devices enabling minimally invasive vascular connections, especially for Coronary Artery Bypass Graft (CABG) surgery
  • Company 960 - Technology for: 1-Glaucoma diagnosis and 2-Real-time homecare monitoring of intraocular pressure (IOP)
  • Company 961 - Vacuum-based clean surface nanotechnology for faster and larger osseointegration
  • Company 962 - Set of catheters for percutaneous isolation of an organ and local delivery of any high-dosage chemotherapy for treatment of organ cancer
  • Company 963 - Diabetic pain relief via topical dermal administration and controlled release of pure Nitric Oxide (NO)
  • Company 964 - Smallest/passive/implantable tag using RFID (radio-frequency identification) technology
  • Company 965 - Non-invasive brain physiological measurement technologies
  • Company 966 - Automated cranial maxillo-facial (CMF) screw delivery system
  • Company 967 - Non-invasive reverse thermal gradient technology to treat conditions of tendons, ligaments, muscles, fasciae, and joints
  • Company 968 - Non-invasive device designed to offer transcutaneous pulsed electro-magnetic field stimulation therapy for treating postoperative pain and edema in superficial soft tissue
  • Company 969 - A-FX(TM) is a minimally invasive platform technology for creating an orthopedic implant in-situ which provides superior fixation in osteoporotic bone
  • Company 970 - Polymer technologies for drug delivery and regenerative medicine with applications in orthopedics and spine
  • Company 971 - Technology to enable home healthcare providers to provide better patient care while improving operational efficiency by 20-30%
  • Company 972 - Digital fluorescence scanners for molecular pathology research, biomarker development, and clinical molecular diagnostics (MDx) for personalized medicine
  • Company 973 - In-line, battery-powered, disposable, lightweight, and completely portable blood and IV fluid warming device, capable of intravenous application and irrigation warming
  • Company 974 - Next-generation stent platform with: significantly thin walls for reduced restenosis, ease-of-use, superior deliverability, and improved radiopacity for accurate placement
  • Company 975 - Handheld, non-invasive, real-time Central Venous Pressure (CVP) monitor for cardiology and nephrology diagnostic applications
  • Company 976 - Ventricular Assist Device (VAD) that can be inserted above the diaphragm
  • Company 977 - NuOrtho Surgical, Inc. is a highly innovative early stage medical device company developing revolutionary technology for the healthcare industry. Our focus is to preserve the normal, healthy tissue of patients that today is damaged as a by-product of current treatments.
  • Company 978 - Computer-Aided Diagnosis (CADx) tool for personalized, objective diagnosis and treatment management of musculoskeletal diseases
  • Company 979 - System designed to prevent contrast-induced nephropathy (CIN)
  • Company 980 - Biomimetic hydrogel implants for spine and other orthopedic applications
  • Company 981 - Portable DNA analyzers for on-demand, non-batched testing, with real-time polymerase chain reaction (PCR) results in 30-60 minutes
  • Company 982 - Articulating range-of-motion (ROM), non-surgical spinal decompression system to treat herniated, bulged, and injured discs
  • Company 983 - Total Artificial Heart (TAH) to replace both ventricles of a failed heart, thus, restoring the circulatory system to normalcy
  • Company 984 - Next-generation remote patient monitoring (RPM) to continuously monitor vital life-sign functions such as: heart rate, respiratory rate, body position, activity level, and skin temperature
  • Company 985 - Catheter-based system to treat large vessel acute ischemic strokes
  • Company 986 - Tissue repair platform that obviates the need for sutures, stapes, glues, or other foreign bodies and instead allows the body to repair and heal itself
  • Company 987 - Antimicrobial solutions to reduce the incidence of Surgical Site Infections (SSIs) in spinal surgeries
  • Company 988 - Non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system
  • Company 989 - MRI-compatible ultrasound applicator to deliver controlled thermal therapy to the cancerous regions of the prostate gland
  • Company 990 - Needleless/transdermal delivery system for insulin, analgesics, or vaccines with on/off control of dosing
  • Company 991 - Genomics-based in vitro diagnostic (IVD) tests developed from FFPE tissue for personalized medicine
  • Company 992 - Cancer prognostic tests for predicting specific individual patient clinical outcomes
  • Company 993 - Drug-eluting balloons that allow for controlled release of different and even multiple substances, for the treatment of coronary (CAD) and peripheral artery disease (PAD)
  • Company 994 - Minimally invasive alternative to the surgical treatment of obesity
  • Company 995 - Routine serum DNA blood tests for early cancer diagnosis and management
  • Company 996 - Point-of-care handheld immunoassay system providing high-performance quantitative laboratory blood test results in an inexpensive, portable, and easy-to-use configuration
  • Company 997 - Elastic, self-expanding devices to specifically improve left ventricle relaxation and diastolic function
  • Company 998 - Microdermabrasion system with polyester/nylon bristle tips and variable vacuum levels for particle-free/crystal-free performance
  • Company 999 - Implantable device for the surgical treatment of obesity without reliance on sutures, staples, or other mechanisms that puncture the stomach wall
  • Company 1000 - "Minimally invasive" gene repair
  • Company 1001 - Joint, spine, and trauma implants
  • Company 1002 - Neurostimulation device to block residual limb pain caused by complications of amputations, as well as chronic pain after surgery, and migraine pain
  • Company 1003 - Advanced polymer-based biomaterials for applications in cardiology, dentistry, orthopedics, surgery, and urology
  • Company 1004 - Hydrogel materials that can be fabricated into devices, nanogels, and polymer solutions with applications in ophthalmology as well as cardiology, urology, and tissue engineering
  • Company 1005 - Non-invasive near-infrared (NIR) laser energy for the treatment of: acute ischemic stroke, spinal cord injury, traumatic brain injury, global cerebral ischemia, spinal cord injury, Alzheimer's disease, Parkinson's disease, and sepsis
  • Company 1006 - Brain training software aimed at enabling individuals to strengthen cognitive function using the concept of neuroplasticity
  • Company 1007 - microRNA-based tests to diagnose various cancers and gastrointestinal diseases
  • Company 1008 - 1-Artificial larynx, 2-Ear, nose, and throat (ENT) prostheses/implants
  • Company 1009 - Controlled, targeted deep-tissue therapeutic warming system to promote pain relief, reduce joint stiffness, and enhance recovery/rehabilitation programs
  • Company 1010 - High-quality, cost-efficient, single-room proton beam radiotherapy (PBRT) system as an alternative to conventional high-energy x-rays
  • Company 1011 - Non-invasive radiofrequency (RF) energy-based system to treat vaginal stretching caused by childbirth
  • Company 1012 - Optical technology for correcting presbyopia
  • Company 1013 - Temperature management technology to treat hyperthermia and hypothermia, prevent damage from stroke, and enhance cancer therapies
  • Company 1014 - Medical textiles for hemostasis
  • Company 1015 - Implants for sensorineural hearing loss
  • Company 1016 - Spine arthroplasty products
  • Company 1017 - Endovascular technology to treat peripheral atherosclerosis in the superficial femoral and popliteal arteries
  • Company 1018 - Low-cost technology to survey the genome in its native state, in context, and at ultra-high resolution, without the need for DNA amplification
  • Company 1019 - Pressure cycling technology (PCT) to safely, conveniently, and reproducibly control the actions of molecules in biological samples
  • Company 1020 - 1-System for use in spinal surgical procedures such as vertebroplasty, 2-System to provide immediate vascular access through the intraosseous space for the delivery of essential drugs and fluids, 3-System for aspirations, biopsies, and stem cell collections
  • Company 1021 - Surgical device for treating benign prostatic hyperplasia (BPH) and other conditions
  • Company 1022 - Neurosurgical tumor removal
  • Company 1023 - Wound closure technology
  • Company 1024 - Radiosurgical therapy for neurovascular and inflammatory ocular conditions
  • Company 1025 - Continuous blood glucose measurement devices
  • Company 1026 - Compact ultrasound devices
  • Company 1027 - Obstetric position tracker and ultrasound technology
  • Company 1028 - Image-guided ultrasound for prostate cancer tissue ablation
  • Company 1029 - Needle-free drug delivery for migraine attacks and cluster headache episodes
  • Company 1030 - Products enhancing focally-delivered radiation and drug therapies for patients with spinal metastatic disease or bone tumors
  • Company 1031 - Minimally invasive, image-guided therapies to treat back pain
  • Company 1032 - System that measures airway inflammation to determine asthma severity for improved treatment
  • Company 1033 - Stand-alone/rapid/autologous cell harvesting processing and delivery technology
  • Company 1034 - Transformative device for detecting and treating breast cancer
  • Company 1035 - Small/wearable/all-mechanical insulin delivery device containing a 3-day supply of insulin
  • Company 1036 - POC/PST device to directly detect clot formation and do it in real time
  • Company 1037 - Cancer immunotherapy device, which selectively removes specific blood-borne inhibitors of the immune system
  • Company 1038 - Diagnostic products for rapid infection determination at the point-of-care (POC) for professional and consumer markets
  • Company 1039 - Rapid/sensitive/cost-effective diagnostic products for detecting microbes causing hospital associated infections
  • Company 1040 - Device that creates a reliable anastomosis to any graft site
  • Company 1041 - Minimally invasive ultrasound-guided RF ablation system to treat symptomatic uterine fibroids through a transcervical approach
  • Company 1042 - Hand-held ultrasound device that displays the image in the medical practitioner's line of sight, at the patient's skin surface
  • Company 1043 - Fish-skin-derived tissue regeneration technology for use in a range of reconstructive and orthopedic surgical procedures
  • Company 1044 - Miniature/high-resolution/low-cost CMOS (complimentary metal-oxide semiconductor) image sensors for use in disposable endoscopic surgical applications
  • Company 1045 - Single-use, disposable silver ion delivery device to treat Osteomyelitis (OM)
  • Company 1046 - Full line of products specifically dedicated to avoiding a total joint replacement and preserving the shoulder, hip, knee, or ankle joints
  • Company 1047 - Fatigue-resistant/fiber-reinforced bone cement for orthopedic joint replacement
  • Company 1048 - Robotic assistance device for CT-guided soft tissue interventions
  • Company 1049 - Non-invasive, easy-to-use device that uses pulsed radio frequency energy (PRFE) for tissue growth, wound healing, and pain relief
  • Company 1050 - Flat panel and custom radiation sources that solve problems in sterilization and medical imaging
  • Company 1051 - Rapid endovascular vessel occlusion and blood flow interruption
  • Company 1052 - Suite of diagnostic imaging products using near-field and forced-resonance principles targeting several specialties including cardiology, oncology, orthopedics, and neurology
  • Company 1053 - Portable diagnostic device used to determine the presence and level of Myocardial Ischemia (MI)
  • Company 1054 - Point-of-care automated optical diagnostic device for platelet quality testing
  • Company 1055 - Sensor-based, video-monitored, automatic/semi-automatic laryngoscope that makes intubation easy, safe, and fast
  • Company 1056 - Enhanced meter dose inhalers and spacer devices for the treatment of Asthma and COPD
  • Company 1057 - \\\"Lap-Pak\\\" is a flexible, one-piece, device contoured to enable the rapid and secure re-positioning of the bowels to expose the surgical site while eliminating the need for re-positioning during surgery
  • Company 1058 - Smart card platform that identifies and authenticates a patient to the healthcare provider and matches the patient to his or her medical record
  • Company 1059 - RFID technology and software systems for medical device manufacturers, distributors, and hospitals
  • Company 1060 - Breast imaging system for early breast cancer detection
  • Company 1061 - Therapeutic ultrasound to treat hypertension
  • Company 1062 - Ultrasonic technologies and related techniques for aesthetic surgery
  • Company 1063 - Home healthcare device for use by patients to self-measure Intraocular Pressure (IOP)
  • Company 1064 - Advanced feeding tube technology which can be placed using ultrathin endoscopes
  • Company 1065 - Critical care monitoring technologies
  • Company 1066 - Polymolecular system for the treatment of inflammatory disease
  • Company 1067 - Controlled warm air delivery device for human head lice removal
  • Company 1068 - Synthetic polymer for osteoarthritis therapy
  • Company 1069 - Protein signature-based diagnostic tests for prostate, lung, and breast cancers
  • Company 1070 - In-situ formed hydrogels for radiation oncology and oncologic surgery
  • Company 1071 - Transdermal therapeutics for neurological and psychiatric diseases
  • Company 1072 - Type 1 Diabetes medication delivery
  • Company 1073 - Dental imaging
  • Company 1074 - Interventional cardiology devices for chronic total occlusions
  • Company 1075 - Gastrointestinal endoscopy products
  • Company 1076 - Human fibrinogen-based tissue sealant
  • Company 1077 - Wireless electrocardiography
  • Company 1078 - Magnetically-guided enteral feeding tube
  • Company 1079 - Auto-adjusting portable oxygen system
  • Company 1080 - Handheld CD4 cell counter
  • Company 1081 - Robotic ankle and foot prosthesis



Select the markets you wish to purchase for $499 each. If you wish to purchase more than 3 markets, your price will not exceed the price for Full Access $1,595.


























License Type:
Single User License 12 Months
Corporate License (Call, Email or
 for pricing)***


* "Multiple Market Access" includes existing content for each market selected plus regular updates within the selected market(s).
** "Full Access All 23 Markets" includes existing content for all 23 markets plus regular updates to all 23 markets.
*** Corporate License allows for multi-user and/or enterprise wide access.